<SEC-DOCUMENT>0001641172-25-020569.txt : 20250722
<SEC-HEADER>0001641172-25-020569.hdr.sgml : 20250722
<ACCEPTANCE-DATETIME>20250722160520
ACCESSION NUMBER:		0001641172-25-020569
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250718
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
FILED AS OF DATE:		20250722
DATE AS OF CHANGE:		20250722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NanoVibronix, Inc.
		CENTRAL INDEX KEY:			0001326706
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36445
		FILM NUMBER:		251140341

	BUSINESS ADDRESS:	
		STREET 1:		969 PRUITT AVE,
		CITY:			TYLER
		STATE:			TX
		ZIP:			77569
		BUSINESS PHONE:		(914) 233-3004

	MAIL ADDRESS:	
		STREET 1:		969 PRUITT AVE,
		CITY:			TYLER
		STATE:			TX
		ZIP:			77569

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix, Inc.
		DATE OF NAME CHANGE:	20111206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix Inc
		DATE OF NAME CHANGE:	20050510
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:NAOV="http://nanovibronix.com/20250718">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_NAOV_nanovibronix.com_20250718 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20250718_20250718 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001326706 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000005" name="dei:EntityCentralIndexKey">0001326706</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="naov-20250718.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326706</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-18</xbrli:startDate>
        <xbrli:endDate>2025-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20250718__20250718_znXR5X6GC5le"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20250718__20250718_zfBVHTpUif2j"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">July 18, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityRegistrantName_c20250718__20250718_zrva5IffyzB3"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000012" name="dei:EntityRegistrantName">NanoVibronix,
Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20250718__20250718_zWpfsn9vFMtd"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityFileNumber_c20250718__20250718_zchOkHqxND3f"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000014" name="dei:EntityFileNumber">001-36445</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250718__20250718_zfkNtKcNT5K4"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000015" name="dei:EntityTaxIdentificationNumber">01-0801232</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityAddressAddressLine1_c20250718__20250718_zaxxJ5ENtGc6"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000016" name="dei:EntityAddressAddressLine1">969
                                            Pruitt Ave</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressCityOrTown_c20250718__20250718_zry0gowk3qZa"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000017" name="dei:EntityAddressCityOrTown">Tyler</ix:nonNumeric></span>,
    <span id="xdx_906_edei--EntityAddressStateOrProvince_c20250718__20250718_z1BjDnfPOdLd"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityAddressPostalZipCode_c20250718__20250718_zNdlQfxgJbWf"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000019" name="dei:EntityAddressPostalZipCode">77569</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_900_edei--CityAreaCode_c20250718__20250718_za0js5ZsjHah"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000020" name="dei:CityAreaCode">(914)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20250718__20250718_zTaxLNPjjfN5"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000021" name="dei:LocalPhoneNumber">233-3004</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--WrittenCommunications_c20250718__20250718_zhBGzhS4IpBb"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--SolicitingMaterial_c20250718__20250718_zyDTthl5ACS6"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250718__20250718_zIgWM0rqMcca"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250718__20250718_zd5gCNM561We"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_907_edei--EntityEmergingGrowthCompany_c20250718__20250718_zKOj1v9vxd43"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20250718__20250718_z1FmIALyLl33"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20250718__20250718_zZWfVDKRg3Ji"><ix:nonNumeric contextRef="AsOf2025-07-18" id="Fact000028" name="dei:TradingSymbol">NAOV</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_909_edei--SecurityExchangeName_c20250718__20250718_zCI5Az8AESn4"><ix:nonNumeric contextRef="AsOf2025-07-18" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities
Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2025, NanoVibronix, Inc. (the &#8220;<b><i>Company</i></b>&#8221;) entered into a Securities Purchase Agreement (the &#8220;<b><i>Purchase
Agreement</i></b>&#8221;) with a certain institutional investor (the &#8220;<b><i>Investor</i></b>&#8221;), pursuant to which it agreed
to sell to the Investors (i) an aggregate of 8,889 shares of the Company&#8217;s newly-designated Series H Convertible Preferred Stock,
with a par value of $0.001 per share and a stated value of $1,000 per share (the &#8220;<b><i>Stated Value</i></b>&#8221;), initially
convertible into up to 8,800,990 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;<b><i>Common Stock</i></b>&#8221;)
at an initial conversion price of $1.01 per share (the &#8220;<b><i>Preferred Stock</i></b>&#8221;) and (ii) warrants to acquire up to
an aggregate of 4,678,363 shares of Common Stock (the &#8220;<b><i>Warrants</i></b>&#8221;) at an exercise price of $2.25 (the &#8220;<b><i>Private
Placement</i></b>&#8221; and such closing, the &#8220;<b><i>Initial Closing</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Purchase Agreement, the Company has also agreed to issue 2,222 shares of Preferred Stock with a total stated value
of $2,222,222 in a second closing, subject to the satisfaction of customary closing conditions. Additionally, pursuant to the terms of
the Purchase Agreement, the Company has agreed that during the period ending 36 months from the effective date of the registration statement
(the &#8220;<b><i>Resale Registration Statement</i></b>&#8221;) registering the resale of the shares of Common Stock underlying the Preferred
Stock (the &#8220;<b><i>Conversion Shares</i></b>&#8221;) and the Warrants (the &#8220;<b><i>Warrant Shares</i></b>&#8221;), the Investor
shall have the right, but no obligation, upon notice to the Company from time to time, to purchase up to an aggregate of $44,000,000
stated value (representing 44,000 shares of Preferred Stock and $39,600,000 of subscription amount) of additional Preferred Stock, which
shall have identical terms to the Preferred Stock issued at the Initial Closing, except that the initial conversion price of such additional
shares of Preferred Stock shall be equal to 85% of the arithmetic average of the three (3) lowest VWAPs during the ten trading days prior
to the date of such investor&#8217;s exercise of such right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Initial Closing of the Private Placement occurred on July 22, 2025 (the &#8220;<b><i>Closing Date</i></b>&#8221;). The aggregate
gross proceeds from the Initial Closing were $8 million, prior to deducting placement agent fees and other offering expenses payable
by the Company. The Company intends to use $5 million of the net proceeds from the Initial Closing to redeem certain outstanding shares
of its Series X Preferred Stock in accordance with the terms of the Certificate of Designations of the Series X Preferred Stock, and
the balance for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains certain representations and warranties, covenants and indemnification provisions customary for similar transactions.
The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the applicable
parties to the Purchase Agreement and may be subject to limitations agreed upon by the applicable contracting parties. Among other covenants,
the Purchase Agreement requires the Company to hold a meeting of its stockholders at the earliest practicable date to seek approval (the
&#8220;<b><i>Stockholder Approval</i></b>&#8221;) under Nasdaq Stock Market Rule 5635(d) for the issuance of shares of Common Stock in
excess of 19.99% of the Company&#8217;s issued and outstanding shares of Common Stock at prices below the &#8220;Minimum Price&#8221;
(as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of the Purchase Agreement pursuant to the terms of the
Preferred Stock and the applicable Warrants and shall hold a meeting every four months thereafter if Stockholder Approval to seek Stockholder
Approval until the earlier of the date Stockholder Approval is obtained or the Preferred Stock is no longer outstanding. Additionally,
pursuant to the terms of the Purchase Agreement, the Company has also agreed to file the Resale Registration Statement as soon as reasonably
practicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;<b><i>Securities
Act</i></b>&#8221;), pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2)
of the Securities Act and/or Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state
laws. Each of the Investors has represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation
D and that it is acquiring the applicable securities for investment only and not with a view towards, or for resale in connection with,
the public sale or distribution thereof. The Preferred Stock and Warrants were offered and sold without any general solicitation by the
Company or its representatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series
H Convertible Preferred Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Preferred Stock are as set forth in the form of Certificate of Designations, attached hereto as Exhibit 3.1 to this Current
Report on Form 8-K (the &#8220;<b><i>Certificate of Designations</i></b>&#8221;), which was filed with the Secretary of State for the
State of Delaware on July 18, 2025, prior to the closing of the Private Placement. The Preferred Stock are convertible into the Conversion
Shares at the election of the holders of the Preferred Stock (the &#8220;<b><i>Holders</i></b>&#8221;) at any time at an initial conversion
price of $1.01 per share (the &#8220;<b><i>Conversion Price</i></b>&#8221;). The Conversion Price is subject to customary adjustments
for stock dividends, stock splits, reclassifications, stock combinations and the like (subject to certain exceptions), anti-dilution
provisions, and a floor price of $0.202.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Approval</i>. Prior to obtaining Stockholder Approval, the Company may not issue, upon conversion of the Preferred Stock, a number of
shares of Common Stock that would exceed 19.99% of the issued and outstanding Common Stock on the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends</i>.
Holders of the Preferred Stock shall be entitled to receive cumulative dividends at the rate per share (as a percentage of the Stated
Value per share) of 9% per annum, payable on each Conversion Date (with respect only to Preferred Stock being converted) in duly authorized,
validly issued, fully paid and non-assessable shares of Common Stock at the Conversion Price then in effect in accordance with the terms
of the Certificate of Designations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as otherwise provided in the Certificate of Designations or as otherwise required by law, the Preferred Stock shall have no voting
rights. However, as long as any shares of Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the
Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences or
rights given to the Preferred Stock or alter or amend the Certificate of Designations, (b) amend its certificate of incorporation or
other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares
of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are exercisable for shares of Common Stock on the date of Stockholder Approval (the &#8220;<b><i>Stockholder Approval Date</i></b>&#8221;),
at an exercise price of $2.25 per share and expire 18 months from the Stockholder Approval Date. The exercise price of each Warrant is
subject to customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like. There is no established
public trading market for the Warrants and the Company does not intend to list the Warrants on any national securities exchange or nationally
recognized trading system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement, the Warrants and the Certificate of Designations are qualified in their entirety by
reference to the full text of the form of Purchase Agreement, the Warrants and the Certificate of Designations, copies of which are filed
as Exhibits 10.1, 4.1 and 3.1, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="margin: 0; text-align: justify"><b>Item
                                            2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet
                                            Arrangement of a Registrant</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The matters described in Item 1.01 of this Current Report on Form 8-K related
to the Private Placement and the use of proceeds from the Initial Closing are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
matters described in Item 1.01 of this Current Report on Form 8-K related to the Private Placement are incorporated herein by reference.
In connection with the issuance and sale of the Preferred Stock, Warrants, Conversion Shares and Warrant Shares in the Private Placement
described in Item 1.01, the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or
Regulation D promulgated thereunder for transactions not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in
any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.03 Material Modification to Rights of Security Holders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
matters described in Item 1.01 of this Current Report on Form 8-K related to the Preferred Stock and the filing of the Certificate of
Designations are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
matters described in Item 1.01 of this Current Report on Form 8-K related to the filing of the Certificate of Designations are incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 88%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Designation of the Preferences, Rights and Limitations of Series H Convertible Preferred Stock, filed July 18, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Warrant, dated July 22, 2025</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Securities Purchase Agreement, dated July 18, 2025, by and between the Company and the purchaser thereto</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>NanoVibronix,
    Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    July 22, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Doron Besser, M.D.</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doron
    Besser, M.D.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVsKwkAMRVfQPYT5lr60Cv20aBGrlCLi72CjDLaTkhlfS3KXTlvEEAjJvSdXiInIaa0aZDgtqwIO2HaNtAgVXpBRn9E5ss02BTcrvCpjWWo7rD8wI8egY+Z+JN19cD6UwTqFcBHEURAnEE7TZAblTni9npG+qBq1VbIBqWsomTpWaCW/xw8H+SJN7XtIOiIbRTqFyA9H+QNxGMWwp4d8Et8MFEUmvMlQnsiZ7p1zrV4WdU/CqsHWxZmR/rf3BcvgSl0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit 3.1</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>nanovibronix,
inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES, </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
H CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Doron Besser does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
He is the Chief Executive Officer, of NanoVibronix, Inc., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Corporation is authorized to issue 11,000,000 shares of preferred stock, 5,397,780 of which have been issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting
of 11,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series
and the designation thereof, of any of them; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist of 55,111 shares of the preferred stock which the Corporation
has the authority to issue, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Additional
Shares</U>&rdquo; means any shares of Preferred Stock that are purchased after the Closing Date pursuant to Section 4.17 of the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Base
Conversion Price</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an
individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of
50% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock and the Securities
issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges
into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately
prior to such transaction own less than 50% of the aggregate voting power of the Corporation or the successor entity of such transaction,
or (c) the Corporation sells or transfers all or substantially all of its (and all of its Subsidiaries, taken as a whole) assets to another
Person and the stockholders of the Corporation immediately prior to such transaction own less than 50% of the aggregate voting power
of the acquiring entity immediately after the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto and all conditions precedent to (i) each Holder&rsquo;s obligations to pay the Subscription Amount and (ii) the Corporation&rsquo;s
obligations to deliver the Preferred Stock have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dilutive
Issuance</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dilutive
Issuance Notice</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
Payment Date</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
Share Amount</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the date that the Registration Statement filed by the Corporation pursuant to the Purchase Agreement is first declared
effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Corporation
pursuant to any stock or option plan duly adopted by a majority of the non-employee members of the Board of Directors of the Corporation
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of the Purchase Agreement, provided that such securities
have not been amended since the date of the Purchase Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of any such securities or to extend the term of such securities (other than any issuance of
Additional Shares made pursuant to Section 4.17 of the Purchase Agreement), (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Corporation, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the prohibition period in Section 4.12(a) of the Purchase Agreement, and provided that any such issuance
shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or
an owner of an asset in a business synergistic with the business of the Corporation and shall provide to the Corporation additional benefits
in addition to the investment of funds, but shall not include a transaction in which the Corporation is issuing securities primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities. For the avoidance of doubt, in
no event shall the issuance of Additional Shares made pursuant to Section 4.17 of this Agreement be deemed an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuable
Maximum</U>&rdquo; shall have the meaning set forth in Section 6(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Junior
Securities</U>&rdquo; means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which
are explicitly senior or <U>pari passu</U> to the Preferred Stock in dividend rights or liquidation preference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section 8(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated as of the Original Issue Date, among the Corporation and the original
Holders, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Purchase Agreement and covering the resale
of the Underlying Shares and the Warrant Shares (as defined in the Purchase Agreement) by each Holder as provided for in the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock and the Underlying Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Corporation with respect to the transactions contemplated by the Transaction Documents,
including the issuance of all of the Underlying Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing
Date, including any Additional Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to the Purchase
Agreement as specified below such Holder&rsquo;s name on the signature page of the Purchase Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on Exhibit 21.1 to the Corporation&rsquo;s Annual Report on Form 10-K most recently
filed with the Commission, where applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after
the date of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designation, the Purchase Agreement, the Warrants (as defined in the Purchase Agreement),
all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Corporation and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock, and issued and issuable
in lieu of the cash payment of dividends on the Preferred Stock in accordance with the terms of this Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.13(b) of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value</U>. The series of preferred stock designated by this Certificate of Designations shall be
designated as its Series H Convertible Preferred Stock (the &ldquo;<U>Preferred Stock</U>&rdquo;) and the number of shares so designated
shall be up to 55,111 (which shall not be subject to increase without the written consent of the holders of a majority of the then issued
and outstanding shares of the Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)).
Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value equal to $1,000, subject to increase set
forth in Section 3 below (the &ldquo;<U>Stated Value</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Dividends</U>. Holders shall be entitled to receive, and the Corporation shall pay, cumulative dividends at the rate per share (as
a percentage of the Stated Value per share) of 9% per annum, payable on each Conversion Date (with respect only to Preferred Stock being
converted) (each such date, a &ldquo;<U>Dividend Payment Date</U>&rdquo;) in duly authorized, validly issued, fully paid and non-assessable
shares of Common Stock at the Conversion Price then in effect in accordance with Section 6(c)(i) herein, (the dollar amount to be paid
in shares of Common Stock, the &ldquo;<U>Dividend Share Amount</U>&rdquo;). No other dividends shall be paid on shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Dividend Calculations</U>. Dividends on the Preferred Stock shall be calculated on the basis of a 360-day year, consisting of twelve
30 calendar day periods, and shall accrue daily commencing on the Original Issue Date, and shall be deemed to accrue from such date whether
or not earned or declared and whether or not there are profits, surplus or other funds of the Corporation legally available for the payment
of dividends. Dividends shall cease to accrue with respect to any Preferred Stock converted, provided that, the Corporation actually
delivers the Conversion Shares within the time period required by Section 6(c)(i) herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Late Fees</U>. Any dividends, whether paid in cash or shares of Common Stock, that are not paid within three Trading Days following
a Dividend Payment Date shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 15% per annum
or the lesser rate permitted by applicable law which shall accrue daily from the Dividend Payment Date through and including the date
of actual payment in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Other Securities</U>. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof
shall redeem, purchase or otherwise acquire directly or indirectly any Junior Securities. Other than with respect to Series X Preferred
Stock of the Company and Series G Convertible Preferred Stock of the Company, so long as any Preferred Stock shall remain outstanding,
neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make any distribution
upon (other than a dividend or distribution described in Section 6 or dividends due and paid in the ordinary course on preferred stock
of the Corporation at such times when the Corporation is in compliance with its payment and other obligations hereunder), nor shall any
distribution be made in respect of, any Junior Securities as long as any dividends due on the Preferred Stock remain unpaid, nor shall
any monies be set aside for or applied to the purchase or redemption (through a sinking fund or otherwise) of any Junior Securities or
shares <U>pari passu</U> with the Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have no voting
rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of
the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation
or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares
of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;),
the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated
Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate
of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities,
and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the
Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares
if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation.
The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to
each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Conversions at Option of Holder</U>. Each share of Preferred Stock, plus accrued and unpaid dividend thereon, shall be convertible,
at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares
of Common Stock (subject to the limitations set forth in Section 6(d) and Section 6(e)) determined by dividing the Stated Value of such
share of Preferred Stock, plus accrued and unpaid dividends thereon, by the Conversion Price. Holders shall effect conversions by providing
the Corporation with the form of conversion notice attached hereto as <U>Annex A</U> (a &ldquo;<U>Notice of Conversion</U>&rdquo;). Each
Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the amount of accrued and unpaid dividends
thereon, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned
subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date
the applicable Holder delivers by .pdf via email such Notice of Conversion to the Corporation (such date, the &ldquo;<U>Conversion Date</U>&rdquo;).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to
the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in
the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred
Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless
all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing
such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock
or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Price</U>. The conversion price for the Preferred Stock shall equal <B>$1.01</B>, subject to adjustment herein (the &ldquo;<U>Conversion
Price</U>&rdquo;); provided that, following the issuance of any Additional Shares, the Conversion Price shall be equal to 85% of the
arithmetic average of the three (3) lowest VWAPs for the ten (10) Trading Days prior to the issuance of such Additional Shares (the &ldquo;<U>Adjusted
Conversion Price</U>&rdquo;), provided further that such Adjusted Conversion Price shall in no event be lower than the Floor Price (subject
to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the Original Issue Date and
provided that if the Adjusted Conversion Price is less than the Floor Price, the Adjusted Conversion Price shall equal the Floor Price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) one (1) Trading Day and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;),
the Corporation shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares being acquired upon
the conversion of the Preferred Stock (including, if the Corporation has given continuous notice pursuant to Section 3(b) for payment
of dividends in shares of Common Stock at least 20 Trading Days prior to the date on which the Notice of Conversion is delivered to the
Corporation, shares of Common Stock representing the payment of accrued dividends otherwise determined pursuant to Section 3(a)), which,
on or after the earlier of (i) the six month anniversary of the Original Issue Date or (ii) the Effective Date, shall be free of restrictive
legends and trading restrictions (other than those which may then be required by the Purchase Agreement). On or after the earlier of
(i) the six month anniversary of the Original Issue Date or (ii) the Effective Date, the Corporation shall deliver the Conversion Shares
required to be delivered by the Corporation under this Section 6 electronically through the Depository Trust Company or another established
clearing corporation performing similar functions. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard
settlement period, expressed in a number of Trading Days, on the Corporation&rsquo;s primary Trading Market with respect to the Common
Stock as in effect on the date of delivery of the Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Failure to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to
or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly
return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the
Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion Shares
upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or
inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against
any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder
or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such
Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>, that such delivery shall not operate
as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a Holder shall elect
to convert any or all of the Stated Value of its Preferred Stock, the Corporation may not refuse conversion based on any claim that such
Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement or for any other reason,
unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Preferred Stock
of such Holder shall have been sought and obtained. In the absence of such injunction, the Corporation shall issue Conversion Shares
and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares
pursuant to Section 6(c)(i) by the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash,
as liquidated damages and not as a penalty, for each $1,000 of Stated Value of Preferred Stock being converted, $10 per Trading Day (increasing
to $20 per Trading Day on the third Trading Day) for each Trading Day after the Share Delivery Date until such Conversion Shares are
delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder&rsquo;s right to pursue actual damages or declare a
Triggering Event pursuant to Section 10 hereof for the Corporation&rsquo;s failure to deliver Conversion Shares within the period specified
herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from
seeking to enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available
to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery
Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in
an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating
to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash to such Holder (in addition to
any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s total purchase price
(including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares
of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which
the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such
Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for
conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock
that would have been issued if the Corporation had timely complied with its delivery requirements under Section 6(c)(i). For example,
if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage
commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the
Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts
payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver the Conversion
Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>Reservation of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available
out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock and
payment of dividends on the Preferred Stock, each as herein provided, free from preemptive rights or any other actual contingent purchase
rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares
of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account
the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred Stock and payment of dividends
hereunder. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized,
validly issued, fully paid and nonassessable and, if the Registration Statement is then effective under the Securities Act, shall be
registered for public resale in accordance with such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Conversion Price or round up to the next whole share. Notwithstanding anything to the contrary contained herein, but consistent with
the provisions of this subsection with respect to fractional Conversion Shares, nothing shall prevent any Holder from converting fractional
shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock
and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting
the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation
that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion
and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for
same-day electronic delivery of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Beneficial Ownership Limitation</U>. The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not
have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on
the applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s Affiliates, and any Persons acting as a group together
with such Holder or any of such Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)) would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number of shares of Common
Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number
of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially
owned by such Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained
herein (including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation
contained in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities
owned by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible
shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s
determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together
with any Affiliates and Attribution Parties) and how many shares of the Preferred Stock are convertible, in each case subject to the
Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation
each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph
and the Corporation shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as
to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock,
a Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation
or (iii) a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Corporation shall within one Trading Day confirm orally and in writing to such Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder.
A Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(d)
applicable to its Preferred Stock provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Preferred
Stock held by the Holder and the provisions of this Section 6(d) shall continue to apply. Any such increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Corporation and shall only apply
to such Holder and no other Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 6(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Issuance Limitations</U>. Notwithstanding anything herein to the contrary, if the Corporation has not obtained Shareholder Approval,
then the Corporation may not issue, upon conversion of the Preferred Stock, a number of shares of Common Stock which, when aggregated
with any shares of Common Stock issued on or after the Original Issue Date and prior to such Conversion Date (i) in connection with any
conversion of Preferred Stock issued pursuant to the Purchase Agreement, and (ii) in connection with the exercise of any warrants issued
to any registered broker-dealer as a fee in connection with the issuance of the Securities pursuant to the Purchase Agreement, would
exceed 1,592,977 shares of Common Stock (subject to adjustment for forward and reverse stock splits, recapitalizations and the like)
(such number of shares, the &ldquo;<U>Issuable Maximum</U>&rdquo;). Each Holder shall be entitled to a portion of the Issuable Maximum
equal to the quotient obtained by dividing (x) the original Stated Value of such Holder&rsquo;s Preferred Stock by (y) the aggregate
Stated Value of all Preferred Stock issued on the Original Issue Date to all Holders. Such portion shall be adjusted upward ratably in
the event a Holder no longer holds any Preferred Stock and the amount of shares issued to such Holder pursuant to such Holder&rsquo;s
Preferred Stock was less than such Holder&rsquo;s pro-rata share of the Issuable Maximum. For avoidance of doubt, unless and until any
required Shareholder Approval is obtained and effective, warrants issued to any registered broker-dealer as a fee in connection with
the Securities issued pursuant to the Purchase Agreement as described in clause (ii) above shall provide that such warrants shall not
be allocated any portion of the Issuable Maximum and shall be unexercisable unless and until such Shareholder Approval is obtained and
effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock
dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other
Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon
conversion of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number
of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then
the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of
shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Equity Sales</U>. If, at any time while this Preferred Stock is outstanding, the Corporation or any Subsidiary, as applicable
sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any
sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire
shares of Common Stock at an effective price per share that is lower than the then Conversion Price (such lower price, the &ldquo;<U>Base
Conversion Price</U>&rdquo; and such issuances, collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (if the holder of the Common
Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is lower than the Conversion Price,
such issuance shall be deemed to have occurred for less than the Conversion Price on such date of the Dilutive Issuance), then simultaneously
with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Conversion Price shall be reduced to equal the
Base Conversion Price, provided that the Base Conversion Price shall not be less than $0.202 (the &ldquo;<U>Floor Price</U>&rdquo;).
Notwithstanding the foregoing, no adjustment will be made under this Section 7(b) in respect of an Exempt Issuance. If the Corporation
enters into a Variable Rate Transaction, despite the prohibition set forth in the Purchase Agreement, the Corporation shall be deemed
to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion price at which such securities may be converted
or exercised. The Corporation shall notify the Holders in writing, no later than the Trading Day following the issuance of any Common
Stock or Common Stock Equivalents subject to this Section 7(b), indicating therein the applicable issuance price, or applicable reset
price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For
purposes of clarification, whether or not the Corporation provides a Dilutive Issuance Notice pursuant to this Section 7(b), upon the
occurrence of any Dilutive Issuance, the Holders are entitled to receive a number of Conversion Shares based upon the Base Conversion
Price on or after the date of such Dilutive Issuance, regardless of whether a Holder accurately refers to the Base Conversion Price in
the Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Preferred Stock (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation or the Issuable Maximum, then the Holder shall not be entitled to participate in such Purchase Right
to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation or the Issuable Maximum).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such
Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common
Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation or the Issuable Maximum, then the Holder shall not be entitled
to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such
Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such
time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation or the Issuable Maximum).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Preferred Stock is outstanding, (i) the Corporation, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation
(and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding shares of Common Stock (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any
subsequent conversion of this Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have
been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation
in Section 6(d) and Section 6(e) on the conversion of this Preferred Stock), the number of shares of Common Stock of the successor or
acquiring corporation or of the Corporation, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in
Section 6(d) and Section 6(e) on the conversion of this Preferred Stock). For purposes of any such conversion, the determination of the
Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this
Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor
to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms
and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders&rsquo;
right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental
Transaction in which the Corporation is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the
obligations of the Corporation under this Certificate of Designation and the other Transaction Documents (as defined in the Purchase
Agreement) in accordance with the provisions of this Section 7(e) pursuant to written agreements in form and substance reasonably satisfactory
to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option
of the Holder, deliver to the Holder in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion
of this Preferred Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction,
and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for
(so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation and the other Transaction
Documents referring to the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation and the other Transaction
Documents with the same effect as if such Successor Entity had been named as the Corporation herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation
shall promptly deliver to each Holder by email a notice setting forth the Conversion Price after such adjustment and setting forth a
brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)
the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any
shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer
of all or substantially all of the assets of the Corporation (and all of its Subsidiaries, taken as a whole), or any compulsory share
exchange whereby the Common Stock is converted into other securities, cash or property or (E) the Corporation shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause
to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered
by email to each Holder at its last email address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such
notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by e-mail attachment, or sent by a nationally recognized
overnight courier service, addressed to the Corporation, at 969 Pruitt Place, Tyler TX 75703, telephone number (914) 233-3004, e-mail
address Doron Besser doronb@envuemed.com or such other e-mail address or address as the Corporation may specify for such purposes by
notice to the Holders delivered in accordance with this Section 8. Any and all notices or other communications or deliveries to be provided
by the Corporation hereunder shall be in writing and delivered personally, by e-mail attachment, or sent by a nationally recognized overnight
courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Corporation, or
if no such e-mail address or address appears on the books of the Corporation, at the principal place of business of such Holder, as set
forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the
earliest of (i) the date of transmission, if such notice or communication is delivered via e-mail attachment at the e-mail address set
forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission,
if such notice or communication is delivered via e-mail attachment at the e-mail address set forth in this Section on a day that is not
a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required
to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair
the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest,
as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Preferred Stock certificate shall be mutilated, lost, stolen
or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate,
or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so
mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of
the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the transactions
contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers,
shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan
(the &ldquo;<U>New York Courts</U>&rdquo;). The Corporation and each Holder hereby irrevocably submits to the exclusive jurisdiction
of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York
Courts, or such New York Courts are improper or inconvenient venue for such proceeding. The Corporation and each Holder hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by applicable law. The Corporation and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any
and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions
contemplated hereby. If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Certificate
of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo;
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of
Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term
of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder)
of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other
occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate
of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Status of Converted or Redeemed Preferred Stock</U>. Shares of Preferred Stock may only be issued pursuant to the Purchase Agreement.
If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status of
authorized but unissued shares of preferred stock and shall no longer be designated as Series H Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Amendments</U>. This Certificate of Designations or any provision thereof may be amended by obtaining the written consent of the majority
of the Holders of the Preferred Stock issued and outstanding on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be
and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations
in accordance with the foregoing resolution and the provisions of Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 18<SUP>th </SUP>day of July 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Doron Besser, M.D.</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doron
    Besser, M.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares of Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series H Convertible Preferred Stock indicated below into shares of common
stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of NanoVibronix, Inc. a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;),
according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person
other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such
certificates and opinions as may be required by the Corporation in accordance with the Purchase Agreement. No fee will be charged to
the Holders for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
to Effect Conversion: _____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Preferred Stock owned prior to Conversion: _______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Preferred Stock to be Converted: ________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
Value plus accrued dividends of shares of Preferred Stock to be Converted: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Common Stock to be Issued: ___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
Conversion Price:____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Preferred Stock subsequent to Conversion: ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery: ______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
Instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
no: _________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
no: ___________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
INC.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: July 22, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the Shareholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on
or prior to 5:00 p.m. (New York City time) on the date that is eighteen (18) months after the Stockholder Approval Date, provided
that, if such date is not a Trading Day, the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not
thereafter, to subscribe for and purchase from NanoVibronix, Inc. a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to
______ shares (as subject to adjustment
hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common
Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 18, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein), in each case following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably
practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.25</B>, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of
    the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
    hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of
    &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market
(&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and
if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets,
Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated by the
OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or
a book-entry certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period,
in each case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery
to the Company of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to
a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant
Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [9.99/4.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the
outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon
any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within
the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive
from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value
of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which
Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the
30 day volatility, (2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the highest
VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental
Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s
request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the date of the public announcement of
the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five
Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
NANOVIBRONIX, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: <U></U>___________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: <U></U>____________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of July 18, 2025, between NanoVibronix, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below),
and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have
the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the Certificate of Designation of the Series H Convertible Preferred Stock to be filed prior to the
Initial Closing by the Company with the Secretary of State of Delaware, in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means each of the Initial Closing, the Second Closing and each Additional Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means each of the Initial Closing Date, the Second Closing Date, and the Additional Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Haynes and Boone, LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning ascribed to such term in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading
Day, no later than 9:01 a.m. (New York City time) on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,
(b) all of the Underlying Shares and the Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without
the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or
manner-of-sale restrictions, (c) following the one year anniversary of the Initial Closing Date provided that a holder of Underlying
Shares or the Warrant Shares is not an Affiliate of the Company, or (d) all of the Underlying Shares or the Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions
and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders
of the Underlying Shares or the Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable
to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities (other than any issuance of Additional Shares made pursuant to Section 4.17 of this Agreement),
and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of
the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section
4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities. For the avoidance of doubt, in no event shall the issuance of Additional Shares made pursuant to Section 4.17 of the Purchase
Agreement be deemed an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(ll).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(ll).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).<BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Closing</U>&rdquo; means the closing of the purchase and sale of the Initial Shares and Initial Warrants pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Closing Date</U>&rdquo; means the Trading Day on which all conditions precedent set forth in Sections 2.3 and 2.4 to (i) the Purchaser&rsquo;s
obligations to pay the Initial Subscription Amount for the Initial Shares and the Initial Warrants and (ii) the Company&rsquo;s obligations
to deliver the Initial Shares and the Initial Warrants, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Shares</U>&rdquo; means the shares of Preferred Stock issued by the Company to the Purchasers hereunder on the Initial Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Subscription Amount</U>&rdquo; shall mean, as to each Purchaser, the aggregate amount to be paid for the Initial Shares and the Initial
Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading
&ldquo;Initial Subscription Amount,&rdquo; in United States dollars and in immediately available funds</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Warrants</U>&rdquo; means, collectively, the Common Stock Purchase Warrants to purchase shares of Common Stock delivered to the Purchasers
at the Initial Closing in accordance with Section 2.3(a) hereof, which such Initial Warrants shall be exercisable on the Shareholder
Approval Date and have a term of exercise equal to eighteen (18) months from the Shareholder Approval Date, in the form of <U>Exhibit
C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Initial Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(o).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Maximum
Rate</U>&rdquo; shall have the meaning ascribed to such term in Section 5.17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participation
Maximum</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(ll).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Palladium Capital Group LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means the up to 55,111 shares of the Company&rsquo;s 9% Series H Convertible Preferred Stock issued hereunder having
the rights, preferences and privileges set forth in the Certificate of Designation, in the form of <U>Exhibit A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Notice</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.12(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pro
Rata Portion</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in Section 4.18 of this Agreement and covering
the resale of the Underlying Shares and the Warrant Shares by each Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).<BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, (i) the maximum aggregate number of Underlying Shares issuable upon conversion in full of all
shares of Preferred Stock at the initial Conversion Price, ignoring any conversion or exercise limits set forth therein, and assuming
that any previously unconverted shares of Preferred Stock are held until the third anniversary of the Initial Closing Date and all dividends
are paid in shares of Common Stock until such third anniversary and (ii) the maximum aggregate number of Warrant Shares issuable upon
exercise in full of the Warrants, ignoring any exercise limits set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Closing</U>&rdquo; means the closing of the purchase and sale of the Securities pursuant to Section 2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Closing Date</U>&rdquo; means the Trading Day on which all conditions precedent set forth in Sections 2.5 and 2.6 to (i) the Purchaser&rsquo;s
obligations to pay the Second Subscription Amount for the Second Shares and the Second Warrants and (ii) the Company&rsquo;s obligations
to deliver the Second Shares and the Second Warrants, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Subscription Amount</U>&rdquo; shall mean, as to each Purchaser, the aggregate amount to be paid for the Second Shares and the Second
Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading
&ldquo;Second Subscription Amount,&rdquo; in United States dollars and in immediately available funds</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Shares</U>&rdquo; means the shares of Preferred Stock issued by the Company to the Purchasers hereunder on the Second Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Warrants</U>&rdquo; means, collectively, the Common Stock Purchase Warrants to purchase shares of Common Stock delivered to the Purchasers
at the Second Closing in accordance with Section 2.5(a) hereof, which such Second Warrants shall be exercisable on the Shareholder Approval
Date and have a term of exercise equal to eighteen (18) months from the Shareholder Approval Date, in the form of <U>Exhibit C</U> attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Second
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Second Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock, the Underlying Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Company with respect to the transactions contemplated by the Transaction Documents, including
the issuance of all of the Underlying Shares and the Warrant Shares in excess of 19.99% of the issued and outstanding Common Stock on
the Initial Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval Date</U>&rdquo; means the date on which the Shareholder Approval is received and deemed effective under Delaware law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; means $1,000 per share of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean the aggregate of the Initial Subscription Amount and the Second Subscription Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsequent
Financing</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsequent
Financing Notice</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Certificate of Designation, the Warrants, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, New York 11598 and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock, and issued and issuable
in payment of dividends on the Preferred Stock in accordance with the terms of the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.13(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Initial Warrants and the Second Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means, the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Initial Closing</U>. On the Initial Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent
with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and
not jointly, agree to purchase (i) up to an aggregate of 8,889 Initial Shares with an aggregate Stated Value of $8,888,889, for an aggregate
Initial Subscription Amount of $8,000,000 as set forth on the signature pages hereto executed by the Purchasers and (ii) the Initial
Warrants. Each Purchaser shall deliver to the Company, via wire transfer to the bank account of ENvue Medical Holdings LLC, a wholly
owned subsidiary of the Company (&ldquo;<B><I>ENvue</I></B>&rdquo;), immediately available funds equal to such Purchaser&rsquo;s Initial
Subscription Amount and the Company shall deliver to each Purchaser its respective shares of Preferred Stock and accompanying Initial
Warrants, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section
2.3 deliverable at the Initial Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Initial
Closing shall take place remotely by electronic transfer of the Initial Closing documentation or such other location as the parties shall
mutually agree.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Second Closing. </U>On the Second Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, (i) up to an aggregate of 2,222 Second Shares with an aggregate Stated Value of $2,222,222, for an aggregate Second Subscription Amount of $2,000,000 as set forth on the signature pages hereto executed by the Purchasers and (ii) the Second Warrants. Each Purchaser shall deliver to the Company, via wire transfer to the bank account of ENvue, immediately available funds equal to such Purchaser&rsquo;s Second Subscription Amount and the Company shall deliver to each Purchaser its respective shares of Preferred Stock and accompanying Second Warrants, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Second Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.5 and 2.6, the Second Closing shall take place remotely by electronic transfer of the Second Closing documentation or such other location as the parties shall mutually agree.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Initial Closing Deliveries</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Initial Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, in customary form and reasonably acceptable to the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a certificate or book-entry statement evidencing a number of Initial Shares equal to the number of shares set forth on each Purchaser&rsquo;s
signature page, registered in the name of such Purchaser and evidence of the filing and acceptance of the Certificate of Designation
from the Secretary of State of Delaware;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
an Initial Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 50% of the
sum of such Purchaser&rsquo;s shares of Common Stock underlying the Initial Shares, with an exercise price equal to $2.25 per share of
Common Stock, subject to adjustment therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the Company shall have provided each Purchaser with ENvue&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Initial Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Initial Subscription Amount via wire transfer to the bank account of ENvue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Initial Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Initial Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Initial Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Initial Closing Date shall have
been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.3(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Initial Closing are subject to the following conditions
being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Initial Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Initial Closing Date shall have
been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.3(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Initial Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the
Company&rsquo;s principal Trading Market and, at any time prior to the Initial Closing Date, trading in securities generally as reported
by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Initial Shares and the Initial Warrants at the Initial
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<U>Second Closing Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Second Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a legal opinion of Company Counsel, in customary form and reasonably acceptable to the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a certificate or book-entry statement evidencing a number of Second Shares equal to the number of shares set forth on each Purchaser&rsquo;s
signature page, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a Second Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 50% of the sum
of such Purchaser&rsquo;s shares of Common Stock underlying the Second Shares, with an exercise price equal to $2.25 per share of Common
Stock, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Registration Statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the Company shall have provided each Purchaser with ENvue&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Second Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
such Purchfaser&rsquo;s Second Subscription Amount via wire transfer to the bank account of ENvue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<U>Second Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The obligations of the Company hereunder in connection with the Second Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Second Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Second Closing Date shall have
been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the delivery by each Purchaser of the items set forth in Section 2.5(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The respective obligations of the Purchasers hereunder in connection with the Second Closing are subject to the following conditions
being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Second Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Second Closing Date shall have been
performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the delivery by the Company of the items set forth in Section 2.5(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
there shall have been no Material Adverse Effect with respect to the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
from the date hereof to the Second Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market and, at any time prior to the Second Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported
by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York
State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Second Shares and the Second Warrants at the Second
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the SEC Reports, the Company hereby makes the following
representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals, including, the Shareholder Approval. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.6 of this Agreement, (ii) the filing of the Registration Statement with the Commission pursuant to the
terms of this Agreement, (iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities
and the listing of the Underlying Shares and the Warrants for trading thereon in the time and manner required thereby, (iv) the filing
of Form D with the Commission and such filings as are required to be made under applicable state securities laws and (v) Shareholder
Approval (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Underlying Shares, when issued in accordance with
the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by
the Company other than restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance
with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital
stock a number of shares of Common Stock for issuance of the Underlying Shares and the Warrant Shares at least equal to the Required
Minimum on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth In the SEC Reports. Except as set forth
in the SEC Reports, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act,
other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of
Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Except as set
forth in the SEC Reports, no Person has any right of first refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities,
and as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving
any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock
or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company
or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth
in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts
the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any
Subsidiary. Except as set forth in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. Other than the Shareholder Approval, no further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer
subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event,
liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect
to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition,
that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed
made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). Except as set forth in the SEC Reports, there is no Action that (i) adversely affects
or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there
were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not
pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the
Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed
by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included
within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of each Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company.</U> The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Except as set forth in the SEC Reports, other than each of the Purchasers, no Person has any right to cause
the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration,
except as disclose in the SEC Reports. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date
hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company
is not in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the
Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or
another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other
established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby is true and correct and does not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which
they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of each Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from each Closing Date. The SEC Reports set forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Foreign Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Accountants</U>. The Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company,
such accounting firm shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual
Report for the fiscal year ending December 31, 2025, unless and until such time as the Company may appoint a successor registered public
accounting firm as required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Seniority</U>. Except as otherwise disclosed in the SEC Reports, as of each Closing Date, no Indebtedness or other claim against the
Company is senior to the Preferred Stock in right of payment, whether with respect to interest or upon liquidation or dissolution, or
otherwise, other than indebtedness secured by purchase money security interests (which is senior only as to underlying assets covered
thereby) and capital lease obligations (which is senior only as to the property covered thereby).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>No Disagreements with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(g) and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, may presently have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Underlying Shares and the Warrant Shares deliverable with respect to Securities are being determined, and
(z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and
after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities
do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Form S-3 Eligibility</U>. The Company is eligible to register the resale of the Underlying Shares for resale by the Purchaser on Form
S-3 promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Cybersecurity</U>. (i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any
Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use,
access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)
the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company
and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without
limitation, the European Union General Data Protection Regulation (&ldquo;GDPR&rdquo;) (EU 2016/679) (collectively, &ldquo;Privacy Laws&rdquo;);
(ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance
with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis
of Personal Data (as defined below) (the &ldquo;Policies&rdquo;); (iii) the Company provides accurate notice of its applicable Policies
to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv) applicable Policies provide
accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject matter, and do not contain
any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws. &ldquo;Personal Data&rdquo;
means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security number, bank information,
or customer or account number; (ii) any information which would qualify as &ldquo;personally identifying information&rdquo; under the
Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other piece of information
that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any identifiable
data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained in any of the
Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery and performance
of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (i)
to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or the Subsidiaries
under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently conducting
or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request or demand
pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to each Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of each Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it converts any shares of Preferred Stock or exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as
defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to
such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition
of, preclude any actions, with respect to the locating or borrowing of, arrangement to borrow, identification of the availability of,
and/or securing of, securities of the Company shares in order for such Purchaser (or its broker or other financial representative) to
effect Short Sales or similar transactions in the future .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
shall have the rights and obligations of a Purchaser under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE] [EXERCISABLE] HAS BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE
UPON [CONVERSION] [EXERCISE] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER
OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES
ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Underlying Shares and the Warrant Shares shall not contain any legend (including the legend set forth in
Section 4.1(b) hereof): (i) while a registration statement (including the Registration Statement) covering the resale of such security
is effective under the Securities Act, (ii) following any sale of such Underlying Shares or the Warrant Shares pursuant to Rule 144 (assuming
cashless exercise of the Warrants), (iii) if such Underlying Shares or Warrant Shares are eligible for sale under Rule 144 (assuming
cashless exercise of the Warrants), without the requirement for the Company to be in compliance with the current public information required
under Rule 144 as to such Underlying Shares and Warrant Shares and without volume or manner-of-sale restrictions or (iv) if such legend
is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by
the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly
after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser,
respectively. If all or any shares of Preferred Stock are converted or if all or any portion of a Warrant is exercised at a time when
there is an effective registration statement to cover the resale of the Underlying Shares or Warrant Shares, or if such Underlying Shares
or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public information required under
Rule 144 (assuming cashless exercise of the Warrants), or if the Underlying Shares or Warrant Shares may be sold under Rule 144 without
the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Underlying
Shares or Warrant Shares and without volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then
such Underlying Shares or Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective Date or
at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing Underlying Shares or Warrant Shares, as applicable, issued with a
restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate
representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or
give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Underlying
Shares or Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting
the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Underlying
Shares or Warrant Shares, as applicable, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Underlying Shares or Warrant Shares (based on the VWAP of the Common Stock on the date
such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10
per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the
Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause
to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such
Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<FONT STYLE="font-weight: normal"><U>Buy-In
Price</U></FONT>&rdquo;) over the product of (x) such number of Underlying Shares or Warrant Shares that the Company was required to
deliver to such Purchaser by the Legend Removal Date multiplied by (y) the lowest closing sale price of the Common Stock on any Trading
Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Underlying Shares or
Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant to
the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive
effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Furnishing of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain
the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the
Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction
or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement
under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company
shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition
to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and
not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent
(2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every
thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such
Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer
the Underlying Shares and Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section
4.3(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public Information Failure Payments shall
be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and
(ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.
In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments
shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s
right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available
to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Conversion and Exercise Procedures</U>. The form of Notice of Conversion included in the Certificate of Designation sets forth the
totality of the procedures required of the Purchasers in order to convert the Preferred Stock. The form of Notice of Exercise included
in the Warrant sets forth the totality of the procedures required of the Purchasers in order to exercise the Warrant. Without limiting
the preceding sentences, no ink-original Notice of Conversion or Notice of Exercise, as applicable, shall be required, nor shall any
medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion and Notice of Exercise, as applicable, form
be required in order to convert the Preferred Stock or exercise the Warrant, as applicable. No additional legal opinion, other information
or instructions shall be required of the Purchasers to convert their Preferred Stock or exercise their Warrants. The Company shall honor
conversions of the Preferred Stock or exercises of the Warrants and shall deliver Underlying Shares or Warrant Shares, as applicable,
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with (i) the Registration Statement and (ii) the filing of
final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations,
in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably
cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.6, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, director, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Use of Proceeds</U>. The Company shall use $5,000,000 of the net proceeds from the sale of the Initial Shares and the Initial Warrants
hereunder to redeem Series X Preferred Stock held by Alpha Capital Anstalt (&ldquo;<U>Alpha</U>&rdquo;) in accordance with the terms
of such Series X Preferred Stock, and the balance for working capital purposes and shall not use such proceeds: (a) for the satisfaction
of any portion of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business
and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding
litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.10 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Reservation and Listing of Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall maintain a reserve of the Required Minimum from its duly authorized shares of Common Stock for issuance pursuant to
the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than 100% of (i) the
Required Minimum on such date, minus (ii) the number of shares of Common Stock previously issued pursuant to the Transaction Documents,
then the Board of Directors shall use commercially reasonable efforts to amend the Company&rsquo;s certificate or articles of incorporation
to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time (minus the number
of shares of Common Stock previously issued pursuant to the Transaction Documents), as soon as possible and in any event not later than
the 75<SUP>th</SUP> day after such date, provided that the Company will not be required at any time to authorize a number of shares of
Common Stock greater than the maximum remaining number of shares of Common Stock that could possibly be issued after such time pursuant
to the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading
Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on
the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing or quotation
on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing or quotation and (iv)
maintain the listing or quotation of such Common Stock on any date at least equal to the Required Minimum on such date on such Trading
Market or another Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through
the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to
the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. In addition,
the Company shall hold a special meeting of shareholders (which may also be at the annual meeting of shareholders) at the earliest practical
date) for the purpose of obtaining Shareholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that such
proposal be approved, and the Company shall solicit proxies from its shareholders in connection therewith in the same manner as all other
management proposals in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal.
The Company shall use its reasonable best efforts to obtain such Shareholder Approval. If the Company does not obtain Shareholder Approval
at the first meeting, the Company shall call a meeting every four months thereafter to seek Shareholder Approval until the earlier of
the date Shareholder Approval is obtained or the Preferred Stock is no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Participation in Future Financing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until the date that is the 12 month anniversary of the later of the Effective Date or the date of Shareholder Approval,
upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration, Indebtedness
or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), each Purchaser shall have the right to participate in
up to an amount of the Subsequent Financing equal to 50% of the Subsequent Financing (the &ldquo;<U>Participation Maximum</U>&rdquo;)
on the same terms, conditions and price provided for in the Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to each Purchaser a written
notice of its intention to effect a Subsequent Financing (&ldquo;<U>Pre-Notice</U>&rdquo;), which Pre-Notice shall ask such Purchaser
if it wants to review the details of such financing (such additional notice, a &ldquo;<U>Subsequent Financing Notice</U>&rdquo;). Upon
the request of a Purchaser, and only upon a request by such Purchaser, for a Subsequent Financing Notice, the Company shall promptly,
but no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to such Purchaser. The Subsequent Financing
Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised
thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term
sheet or similar document relating thereto as an attachment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:30
p.m. (New York City time) on the fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice that such
Purchaser is willing to participate in the Subsequent Financing, the amount of such Purchaser&rsquo;s participation, and representing
and warranting that such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent
Financing Notice. If the Company receives no such notice from a Purchaser as of such fifth (5<SUP>th</SUP>) Trading Day, such Purchaser
shall be deemed to have notified the Company that it does not elect to participate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If by 5:30 p.m. (New York City time) on the fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice,
notifications by the Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to participate)
is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such
Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If by 5:30 p.m. (New York City time) on the fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice,
the Company receives responses to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of
the Participation Maximum, each such Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation
Maximum. &ldquo;<U>Pro Rata Portion</U>&rdquo; means the ratio of (x) the Subscription Amount of Securities purchased on each Closing
Date by a Purchaser participating under this Section 4.12 and (y) the sum of the aggregate Subscription Amounts of Securities purchased
on each Closing Date by all Purchasers participating under this Section 4.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company must provide the Purchasers with a second Subsequent Financing Notice, and the Purchasers will again have the right of participation
set forth above in this Section 4.12, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated
for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial
Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Company and each Purchaser agree that if any Purchaser elects to participate in the Subsequent Financing, the transaction documents
related to the Subsequent Financing shall not include any term or provision that, directly or indirectly, will, or is intended to, exclude
one or more of the Purchasers from participating in a Subsequent Financing, including, but not limited to, provisions whereby such Purchaser
shall be required to agree to any restrictions on trading as to any securities of the Company or be required to consent to any amendment
to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written
consent of such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Notwithstanding anything to the contrary in this Section 4.12 and unless otherwise agreed to by such Purchaser, the Company shall either
confirm in writing to such Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly
disclose its intention to issue the securities in the Subsequent Financing, in either case in such a manner such that such Purchaser
will not be in possession of any material, non-public information, by the tenth (10th) Business Day following delivery of the Subsequent
Financing Notice. If by such tenth (10th) Business Day, no public disclosure regarding a transaction with respect to the Subsequent Financing
has been made, and no notice regarding the abandonment of such transaction has been received by such Purchaser, such transaction shall
be deemed to have been abandoned and such Purchaser shall not be deemed to be in possession of any material, non-public information with
respect to the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until 90 days after the date of Shareholder Approval, neither the Company nor any Subsidiary (i) shall issue, enter
into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or
(ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until the one year anniversary of the Initial Closing Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or
other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;,
whereby the Company may issue securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.13 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.6. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.6, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing, and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.6, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.6 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, Affiliates or agent, including, without limitation, the Placement Agent after the issuance of the initial press release as
described in Section 4.6. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at each Closing
under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions
promptly upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Additional Investment Rights</U>. During the period ending 36 months from the Effective Date, the Purchasers (pro rata according to
their initial Subscription Amounts) shall have the right, but no obligation, upon notice to the Company from time to time, to purchase
up to an aggregate of $44,000,000 Stated Value (representing 44,000 shares of Preferred Stock and $39,600,000 of Subscription Amount)
of additional Preferred Stock, which shall have identical terms to the Preferred Stock issued at the Initial Closing and the Second Closing,
except that the initial Conversion Price of such additional shares of Preferred Stock shall be equal to 85% of the arithmetic average
of the three (3) lowest VWAPs during the ten Trading Days prior to the date of such Purchaser&rsquo;s exercise of such right. All deliverables
for each additional purchase shall be as set forth in Section 2.2(a)(ii) through (iv) hereof and all closing conditions shall be as set
forth in 2.3 hereof, as applicable (the date of such closing, the &ldquo;<U>Additional Closing Date</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants and agrees that it shall use 40% of the proceeds from the first $10,000,000 Stated Value of such additional purchases
to redeem Series X Preferred Stock held by Alpha in accordance with the terms of such Series X Preferred Stock; and 50% of the proceeds
from additional purchases in excess of $10,000,000 Stated Value to redeem Series X Preferred Stock held by Alpha in accordance with the
terms of such Series X Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18.
<U>Registration Statement</U>. As soon as reasonably practicable, the Company shall file a registration statement on Form S-3 (or other
appropriate form if the Company is not then S-3 eligible) providing for the resale by the Purchasers of the Underlying Shares and Warrant
Shares issued and issuable upon conversion or exercise of the Preferred Stock and the Warrants, as applicable. The Company shall use
commercially reasonable efforts to cause the Registration Statement to become effective following the initial filing of the Registration
Statement with the Commission and to keep such Registration Statement effective at all times until no Purchaser owns any shares of Preferred
Stock or Warrants or Underlying Shares or Warrant Shares issuable upon conversion or exercise thereof, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Initial Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. At the Initial Closing, the Company has agreed to reimburse Alpha the non-accountable sum of $125,000 for its
legal fees and expenses. Accordingly, in lieu of the foregoing payments, the aggregate amount that Alpha is to pay for the Securities
at the Initial Closing shall be reduced by $125,000 in lieu thereof. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall
pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered
by the Company and any conversion or exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection
with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the e-mail address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Preferred Stock
based on the initial Subscription Amounts hereunder (or, prior to each Closing, the Company and each Purchaser) or, in the case of a
waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or
waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of
the Company in Section 3.1 hereof and with respect to the representations and warranties of the Purchasers in Section 3.2 hereof. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10 and this Section
5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.10, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive each Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of a conversion of the Preferred Stock or exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common
Stock subject to any such rescinded conversion or exercise, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Usury</U>. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any Action or Proceeding that may be brought by any Purchaser in order to enforce any
right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document,
it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature
of interest shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;<U>Maximum Rate</U>&rdquo;), and, without
limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums
in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed
that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by
statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will
be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded
by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser
with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal
balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Purchaser&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood
and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Saturdays, Sundays, Holidays, etc.</U>&#9;If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22
<B><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>nanovibronix, inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email</U>:
    doronb@envuemed.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doron
    Besser</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynes
and Boone, LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
Rockefeller Plaza, 26<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10112</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Rick A. Werner</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO NAOV SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ___________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Subscription Amount: $________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Shares: _______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Warrants: _____________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
Subscription Amount: $________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
Shares: _______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
Warrants: _____________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>naov-20250718.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCMWbP9z5Z8mekhvWB/bdn6ryUtxxqKfiHiCHw2YQMD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:NAOV="http://nanovibronix.com/20250718" elementFormDefault="qualified" targetNamespace="http://nanovibronix.com/20250718">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://nanovibronix.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="naov-20250718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="naov-20250718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>naov-20250718_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>naov-20250718_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="naov-20250718.xsd#Cover" roleURI="http://nanovibronix.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanovibronix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001641172-25-020569-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-020569-xbrl.zip
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MU3J5=KNI.G/8;<UMF9;9FJ>S&9>Z#(5E*'<6E1G8K[6V<>F5TT9$R"-^DDK
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M@D^BL1.+3^XB+O:#'^4QT761)EI))$6#"6X8.(BXNL8I\R3;Y_1':1-E*"/
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MA:[8W[-V<F6'VVFA2D8_:*TE''':<? :.H(-5&.K4C?3>>GTPWM9Q V!]\+
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MI?NZC4=4Z(P"1H13B1X5'<IZ"!5"=.*FYD@7^)JY&(Z4Q%J?N=JE6[=N6K[
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MLY4Y0[J9%Q5E>1-LOHR6G<M#1Y89N&K7<&=Z%G%"K#J$<'FA,2,198C)^2K
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MS)7+PN5W@&/OQD1'T ,QG8 ^? !A>W7<E=DW[]<5!E./(^3Y"'4,<FS6@'X
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M ALCHV;-C [H;WGBTZ9Z?LTT8W24X/5R=5,MHR4>BHOH*OHSY0-11U.IT)T
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MLU3F<@HVD^[W1XQT!3 EISDCUQ6!?Z'J8**YPV@[1MF>;<38[@K'R#A>3J-
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MWDMJ"D^6^=K^X UJB81+$)_37H(GT+<7Z$K2[,JJPW7@%QVL.&J7>=;_H4F
M"3C:WWWURRXU#[YZL,N]YN8E+PX/!LGKO5>[\.GC7Z0'9S"2\G>S?%\<'_YK
M]_C1J]W!/KJ$,)3D'";[AP/WN-=[!]#YO<$^O.WD=._TC-YU^NO@%#<,?$Y6
M$KP%'KEW2LWZ???D]%!U'W'MO=J%YW"+C\]@Z+@6*+H"P#7E)6#:0G_%!L,.
M.8.-ZS_]Z2_SSYT/>++.!]QG/N#)5YH/^,J+!>Z>/[#N!+J9#(<A;$W)_Q67
M-7"@8<<5B' ;9=)QH^\FGJXMU^>,ZJ-1ED[8.;[ X#,R/JF>)M:E(Q\ VJ4U
M,NJA&SJ91 Q7>KU/R>82YG;@5H2SW*&&<W,C[1(-R[F]E%V JL/RL;>__2>=
M<\?H6Y_:[F /<)35?]S<X-$=)9K)#OU4Q8K0AR2,+I\BZF=46B28K(LLE)5W
MD5E/5)"2EA<7)8*OTDDK1^Y8XAEHH;X[?(A_H9$#+?3C1O6#%E%PA/Z"3?5>
MOXQ7F%"AV 4NE^WD];QJ+ID=FD!M"(CM?EV'EU_MZHZMY'$7BB)(Y3"B0N6^
MDOBQC$3\?(]XWMS0I)&#SNI09^W96(3A)XG:N#"*RBM&DDK1V>LL_;5GOR+=
MHF+YEZ14AB@6^&Z&@3E&,.*<GN&Q,5DP-I+R9XI_DYIT_;7/U4J>C[QY\>U;
M\"+YK0>CH2I;&%44S&#O1ZH)N;[,)YD[J3L1T-;CXV03/8:5Z8>@S<+T2_M(
MCW<J$/ AUV7GJ[ =N9@$Q]OL [L#)RG2UKC9RTK#N,@S7\^G%.L8IO4E40\J
M(X#N-N4$Z/65^.BF-[?>BMPV<(Q<Y,2L(4A82PO^ :U0L!R/KA,M<;EA/= X
MWAB)JE-V6H6W"84?U!_HV:J<.JZ=J4?&QY=KN_/%R#7VJIS,IU*$ "==]:@<
M/Z*QJ$Q:A_5CK_P0\P+F8A(?U]5+ULJE1,1;VN3V?O'^"?\14P$NZ5F565P!
M7!P%7&M#>1C),F!8C2%WL!G&8W-+BH1VB\%>$N[IO.:"';TG$2B(S^-HG+E1
MY59WR2XN+) )]88""B3,&HR4I^-&-LRNVT3$K6EM$<MTYY_JT_&\@J;VXI<C
MPV#,,7$QUJM*>/ ,&IQJGV8J1+.=[(W92JMNX=[ G2$T'6SKY,$7!0O+D4M=
M5[G5!2!+E<Q1)*VCV:DRL?5NS>40':)*K_DC*GX2=[:U#DI\*Q "I+45A/6,
M)$;:NZHE;)E315_Q%S8NOV%SHWO )'<Y7[AO=QR*FWHF>Y\WSL<\J3I#&CNH
MX.9;>DI_R$$5GE%*QN]IEI8>5BQ)^I%/J^2FPXH6F.#O[S+'SNR6QX\Q)5'R
M?N7NU^'Y9]U)?W='3JL2EJG+X^%>5O82.ZJ4Y\BJKH\5ICG QG*\/7WZ6MI8
M+84LK28Y6]%HZR"ERM:3'IZ.(^&/7WC:=_Q",9^>\^?E,]#F!0N#5+DOC$>H
M%HIZGF1-,^$%?L15*EO&H3S/8!1ZK=%PI*?AH>JJ!5O%>.WK <_&H3<JPYJ4
M.YUC+?91F5_V0.ADYR5_Y2Z&+4>GW-8<V^</',M]@M,;BL6H/T55I?-:>%D,
MMJY3.Q!V#]MC^L?F)/=,W7Q:F!2OP*5IFV]X.6,+%D\QPC]RE2K](&GC0GAV
MD&NTI@5[P40VB!:4XR!^?5.KLF("GDBF%XTY0@KOV%D+O;VND\!MP*/S3F>:
M<>YEZO2F]]5%;E]30Z98!G6#T1":(O Q#J2X:@0E0FRSCSNW&W8-['#!TKOS
M_54V*^N<,OZG%7AC;DY$ !?W$-5^Q/AH*3D_KUU)0]]*Y2[?F5:W"16J:STN
M^?.U_SS7FR&A+"Z]6A"F2XZ&_A($[.8&=CVE'O*G?TNKMUFSK-YU2OX464F4
MEA5S31X^$G2)94R^TSFP?+7<?! DW7-@'7A8D6X1]]A>X8K_;RC0DA(JKJHQ
MG+]AF(S/C%G*A!&V+!3M-S O^XF0+E,X$LZ;20[7-B[:$3+U35.-.9-V$07/
MLB*=(/ 8#S=2"_CF2?_QX\>XL.]BGFR=I[77F/O]S>#(VCQN+YGM([9/BX06
MCDPY Z/G><]<56,B%@T\I\AE*1 H/8?;MLHW3QX3%[,]0\CPPQ"A((:^>?HX
M:7^$Q+&W=GJA6>(]PLA-W/-C:Y_DOK.Y$?D2V%E-/N'E8H\7TN/3D5"[.;6=
MWI(XB5TX8UA7=%-B/%V\8!-EW5*S@(P?:Q?T6BM-;ZA8BV\X!UM&=EV&EH=M
MJEPS1I+M0RP,'HES&H@;)Z=M]?C2Z2T*[R&K!SB$4[XS;#FAY77M&6<[6/>-
MZRFE4A1BY[QK\FZB//I=?YSP@J%M''^K5 DZE:];OX!DXRE%2.)1@."E!(Z+
M]K5;_9U@D0@)8I*8(): 4WEVN\C;+62J-VGO93H$"]*$3*=DYE![G:6.A//U
M3<7"K%KO*G'!(  GUWAY;!9AXG/H'+7:+"IH&KJB,^AEUF@&HZ;<$[2X1V M
MMF+B(U/[,N#1/;X768Z]%]"YMJXS1"W^B'P$TW0"%]O9SR_FBT=[L)".< 30
M$),[UVEANK@,^+8H]TP.V[L>#ZQ?1G>Y&3K<-L@]Z]Q(K-74G='U/6XX9:@T
MGL0A\5-;"W87P:_#9,Y0E&YHZ?,T+[F-L$&!]WDCST'+^FN[CZW6MQW(L:;%
M-&(:&[[-C?;-FK)E3$P!'.GI64Z"5IO8-]1&47@B79 9;3SVX82</[PBOA(K
M\A9\R],UON4^\2U/U_B6KQ'?0F28;86S.KMBU13G</Q9YD6C_!MX=K7DSH@O
M@H*7'>7HF&U!H $BYJ>(A2DTL?E&PQT5Y"-NCP-;SIR6YH#2QLUK?^3:!_8Y
MN%I@J'\Z\^@*IN;CK /:M...&X2A_!#;$\_TDDVT<#SI]+UX$!]!+6E+8")@
M26E4V8W 2!TBQ4BB*N)ND4DWM-&RP &PLX-AYAMB;D_0U$>U=GK.*)G/EI8V
M2T_E$WD=$BA])3?<:M?>/1=5Q8%;=ZK&]"J?S#W?9Y#AB*[1%JE<%_I#G+FP
MWD;R8,=O.6\\M<LRCXH+J-Q7-?/&-584:F$S:R@D9.(P>C;-L MC!EA%>4LQ
MB=G1,7<AD393Z=VX?+S*ETN#QY.,YNSAR/*2E^)A-2]<]X0)*#V'@T@Q7'CD
M6Y@;^G9$68#6:H;_&?<I.P_&!QBF^932%.F"A6-&'-^G'#<2%4_$Q6M\&1KS
M'XOEZR:5O5=Z8'"%>"9$$3(C?C;CJ8Z2[IOXL5>9(Y;Q%Y%;;^[!<DZ5UZ)&
MYQ88376-"^D2SFFL+ JA?NMRVB^\2\^WG]$I]7I>%7E]*62XAI3X)UA)E")O
M$Q4_J&%XJ'%Z+)0^HWAK*U>-/WIF0XRM%Z4-TUT7M;UG"$(E"6P%=?#1D+V;
M8=@C#.<C"J:@SQ!'+_.?*6(CK)[MA##X5E"KZ<E3C'7"Z^$?%SW]PNX[:&<!
M[HZ I15#/L$P-EBQ&/85DF(8WZRHE0/$$^<:06'Z"EXP4JMHS.&+*AUJV*0G
MP5FFP#;Q'KPO\1DNR^FN<Q>?M5I#G8LHZ VJPK>#W(("(0"/N7=X."F:"=LV
M9O;;)W]^HW&]9>]:K3O@.YPVZ(WA.Q=OKO-WR=:WO03V$7$5%.BZ"9]Z9P6:
M6%L D^%"#5<-$=2L6T367\:**J9J:XA"5CXN3! G?;K!-1#XS9M^4=AMO[UK
M\%#CO"(FB:AQ'(5'I#R%9BEIL;@C'HQIF$),&+3?'8U(]8B! 2'%+]@8)8;M
M(?BFIOH#OYACQPDPA%^ \:'TI7XG8"M2M]K43YANF7X(^[VD9 -/U+[W:2_9
M2@W$IGN_)Z_AR?!FB[213$7ND[Z4I?C86=]HQC<Q"5^6.PPSON=NE@-#FDSP
MO BL<*775L;'N"*BS=!(TWQFJ;DN<6<.:7UL/=U^_'=W3Z47%VAYP\X[ 7\*
ME@%'3 93A;0L&3Y[\VHP?*&D#,MFRZG78= &;Y8<"W=@_K>>/?[GR=G1S\WE
M/_^!_^W1T[9F59FP9#EN#3Y;)*.$)P,Y"P)SR['H!+Y4]SBFPA?;/&988![6
MG3>:[US:9(S<4UV+9C5;AQ%7X73W9!S!I^>/(3K ^7$U4''',((QCYTO[.9*
MZH$>S)ZSS2$[Z!,&AQJT"$(I31\.VMP RQL[G!*CB("8X4-"K@8+^BX[-#F2
M]I!)KN"C.WR>F[JY@=3V:>Y@#BTT(R6@4/5&EA]G;289 IKDJI'K*>#1O_WM
MV&OP[N>5S#UJ:LO[<+7!6GA&2[8:Z9)]H5IR <* S"6"M(_E%1><B*U$1IZ7
MP^T-TH6X3;@6_^0HUH#P?'=Z:B%H\LE"@+_].X^1GO(D,N?*%C5L*;FQ)]L[
M?R<D!T\&[FFSI>7@I+_5/=FO--W0L/%\,B%F0'+Z DX_NFEO9V>DM8T(O09/
M0CV3_29<UL6^0%B"F'>,E\:^A$QOE0O7>X6NH)Q&!;5QF0V)],47MP6/4N2R
M%L2Q:I@G1L)<21H[0N:?WXY>+>?W,X4UGE-88P_VS47E@Q:1>AH*YF4([B8Y
M(%]/A?]E]2W^"TM5SA>A[G&1790-581Z]]*9':XL;2LL E;O]FD\/]/CRX_+
M:LF"YEXH=I)";]18U]88[TXJ9XYYFJL2Z*:-EDN=BY!"_#UE]0&-Y:O8/&7,
MFA'(VN:<UXITJ"1Z.9^DGIFJZ$!>V6P0=2QNBG:4XMX<G?0%R21UX& V"JY0
M@TSHW$Q\>%Z0.11]5EY+K('P^)C<C3X4(^J4-@[ 5NLPVA?>I>?;.ZS!0E5E
MI'V 2W)7*YV.JG((S@3L?'_ $%,=S/N!R!1BRL5]F^\EY27.+!"?DD-9#=U+
MU86K?2H3EVL3Z";-W+N#TO66">RHZ*D\C6KC^"-A[=RRIKN>:L.=TH<:S6$S
MD[_>2E=&9MZRG;RQM[BK#T!.X8R. I)>A)N[IC*=O'C[J 0K(L<,3G0BX,CI
M]K*#6>^0 [ ,CK#QH3,.1@G\&Y]X,4^QJ9D$(/D46<SH!?YO\">L ZGR_Z99
M[NF1%FTDKK4[M!*GC8QYRX!PEUFW:N5VN%MO0$/12KT%=:9]Z:IQT"A@$Q2S
M1$D6NLZ::6I>W=;8W$'SZMC-?ED6>,@/W6BZJ^5&R?96[2(;J_1 A?5]0!$4
M;1JL9:E&82$B\7GTK3@A17N($$5<\A:F8$GF\L'?)#?"W9ZMX6[W"7=[MDIP
MMP>WTE>]2\^WOR6;R1CX^^EUG;QR$D<:HW*B==W3&P.)DD_SWZ,W]QW= 57/
MH5^>(918%)0T6_)! FGGB[Z+18Z9MN2EI 98_!8C9:_12/K^T;\LCF[IN8P7
M@6KL2MZQ*?L!$%  \C8'21= FW(A2.<EKZE>!+$I+AIFD4(<.K4#% 3?3=UK
M[0-E_BH67\J$93@,.UGH.&/D#OZFP]PW^IM!K#8HB#&P<?\VL%S"Q&DH?8FQ
M\WR4@\4D) G^(7FE/C<&:)RP5V)TO8QFE]'0Q*=<M%%&S)[=CA116T-QSGY<
ML>.FQ64+8#M7=V)JZ?J*R"$&&X4(OL?,WL+#)JK#HMT12I%Y\0R#T]*DERO!
M9Y3F]65&5E]+Z+ /-EYSC2DPTZ3^LNE\W]G<W-!9>X]IC<;_HK.J.*<"%6ZQ
M/$=E9R-+MMURVXK"H*/X0;R/\" "AT1@9.<TF^"K*&8.]@RKVO,""$]%CP!U
M<M;C',XUDM-KN HODHE "1U35.%47QQ&PY<"TS'6$DU9*G36 BYB"#_:!!*L
MF4A1,GU"G05:TPI!%GE$NZCK:"'SK<>WL,L9=+0V4A5UVTW4LL%%9&?1EWRT
MSU7RV\24)X QB7&JSL;J0VAGYNO7W89H]XT*TX(WBUMHLJ)E%:3>.R_(6D!U
M_+!CTEGZDK!9E,?19_H(J5'G)AP /OH2##'6D)ZDBXS*V9' WW&8>$5#&&(7
M>:2C<))>TQDJKTO%^30W.!/=2898"(J\\H#;7?PQ&DP>CL(YR]$IHGV+ (IY
M(<)_MZHC=3/6.""=VY ^5Z33)1,GT1/W*=;C#%:CL*[A,:(BN2T#P4$8*!Z*
MY 9XV@WIY XCHOW(2M&3VJR85D&JFT(TOM*0_SVNE1&["#5S&,?WAVPHTED,
M"8\I5!.WH6*#H6::JY5L:,EV5E[26GC=P;(!9O;46^NR!5@PJ]"83,L7H6G.
M#&\ J@:/%*^=]UJ2&!B\*.$K>&-$1),%UNMX2_Q['E8P0&LY/Z'(WL=WD;YC
M%\ED%(Y9BP.L$DE6@3/.:&\MAB%=6+0/"C(5.H##LC*.Q;*;IRTZW1<+HG48
M67I;*F/ 381+C;]ER4Z\?8@7<E5..%$"ABA\IV:K-CG7!#Z<ON=Y(6;8K,P1
MIS/+$8RP%98E!54]\@XG6**&:,]:K5BP\*B!.YJJ?;DZJ KT7PWO295X*$LZ
M*F>-(>1S@Z7IK7!PAIKL&F$C&'X*#;OP)<97N0LX>G.AVQ["*EWE53.GT\(5
MD@?0NUOJ)/"1?@8$>>58DB/6N,.3^</K89T7#S*D\CV=%P?@8R\!Y&-X ._N
MF-6L3KK01XO_H!'G6R,C7>=U<\.4S CX1UT.'Q^PZ"=?!_?M,K!XVU=5(SYO
M^LYXMR<7:4CB9A$ZK?,,FC#FTU(OZ7#CEJR\+.+=9 HRAZ:3^+*1"VJ$%[BL
M^TJ9IDT/;.))GEV);*C_@AOX>'"DKYEEMALD.G0#-D8.=4[P& TH3N?#Z3$S
M=IWMBQO;X)O=<M0R>9ME,RD$,M^WL8*[.::)\TLMY<FG<$P#@[#-UD .XGW$
MEOI))Q:!#S!Q (E\U0E7:77C9.$4M0AIU(!?@A&5E1#N)?:!;]A2L97%$%JN
M(,-K=\ZYVW9TJ*V<]A$B=)L;]QC+06N!^G+'AOMVDPUPOZ'%N[>;*CT(M3K*
MZ&3#3YVG-<),Q@(?O"WFVM?C;^27?WL+5AD6YK3H^K7N!=RDUCXR1J)X-^X5
MH>3A(BZ0W#Y&A6?<')%+ \C>RVFLW(1,5[CVNMX:V(;S"9Q.63FO;8F^);IC
M$ACN%D7][2]BOJ=VF2!$-Z4(WO>H_* 0'KFL'W)4/B@3Z4-84IZOT\;WF39^
MODIIXWM<[VOGY1;GY0=R7LXXX$R0N6Q4+\O\8BSLFQWD:E2^1@J:9@U#R>";
MIN[-H%+WBISP[BVI"_VU GI8P%Z<ZA)+@<!5IK;#E_[=P091E!MLJL%D=@DG
M?3K+D7)M +=9.FF2+1,AP0\$)5,W07XH_BM\D?$W^[JO\W1"3T"4['59O67.
M=6Z(0\UZF!+%Z^M,LQD\9#]23-?1N:6>K\]%HEN\>&U6DE%V#OVU4L="PU6.
MV5K!7Z#UX$0_2[RUL081O*RJDVQP#];($&=NV!.:5=BX848"&>>^X3A;PCLC
MK0[YSZKPY]W_-\^OL& %K3&LUG,#X,EXY3D!6088O$HK@?5](YK+J[R<N+KE
MUR^/!OBWP]>#ES9^_+#NU >M!/]82@1@116,P)6Y]7$Q/J).PIKK,+S7)OEY
M'!& RN4=''K#<&_+V..ECQZ)<2^\SV%PYV@P9\A6"/_ Y%>1!9Z(.'P4WMAR
MV6L3,ZF5?GE,92V(Y@2K.'/[9'.C*I5=4Z(L^&*78Z"Z-JI'#W)F:4)6D)YI
M]*DD"-G0KV W<\?YR=>7I8:,ZY9KNKFQ9> P2*<M8'K'#+ 3+YZ@$7 %%N[Z
ML-B9GC]:;Q]N#SGHC#N%XMW(?]!P)Q\RVM"D.PZW^X2,,B7;9M*R+9P*K(2R
ME8;J?1QA8C6XS6!0IA2K8J):U7&C@K&R)OI.\("ICI;# !Y"TN<\!N-<T4?!
M\G7\C!2-X>]KB588,E"?#8!W_#EG!B6$UE+];*VE;)L;_C2G1\VKQCS0BZPE
M*5CL59$M:KE[DK%N&?XX1@5(OL]Q"JG/VXJ;T.A037P]E]H6=,)@'7(ILG R
MP?.HV!CO!H[346(5R8 KQD*,+;S$(;)TU*[99,EYA#2F4YKX?LTYH3 /) C]
M0/R]=%7EO#Z6IA(X"[E(Y&^J>XAH+Z$7"J,)1ZP/J-EKL$M2A/4I49QV;BJQ
MTS"LXL,FE FAD?9L0BV#@8X+X<( \\-]MUM(S?,3@BS85?>#_6%0K61+2X%(
M#7&HU<C@^F&1)W.&$VHK];%?/]EM FAJI^%]6SK_'#+1%7"'C%" UO(Y(CU"
M:B$KCRUIB@2Z@#@7+]E)X8<[:ZB.$,4>J4PA 2^H/C<*'_ X*DQ'("WOLF=Q
MC@&YLG,^0U7 !B$8&0.K.!/G(TUP4J7S43^YJ.!\PDH].)#((2V98W$\GR33
MO)97][#V=VS7OHO G%?E'.M1XP1;W,"P_$^:R_>^C"O19]!S.E7A X^KBRZ1
M-A &0U/C,/?KH_H=PHBEQ;6DX"30&_ ]"H8[$$<(8X>,%">QK5T7R?"R9(2.
M27Z EY/-&CIB.Y(>U/YM<)BZ0[:L67RGPE*!BY9X];49<L;8O<=\P)62<>LA
MU^H.II_YX'(GOMXSYHKDE[A9E\"I?- [;.UN"&:FZ:8=% G#'9I*03F-+]*%
M$%.(%A\SH>B\N2PK,%,[J7TSO:98WL7]X6E8GIXI&CBUUY[PQN#!E[/@KDR\
M\&+P4 F/D@R^F_E*!0J+8-RI'ZBAU]<A-R\TDJ[RG+X]#S'L.<E9>\2F1@2)
M9U/6I.+2=4K="M>_+YV=&,PLW!848:WAR*Z=GF*K.]$U4Y3)E&L],:M?*-F%
M+EKM>!C@(&] A'+16.(-$SM.##S(7^)("JX\-L:##76>^ &*(LY"NIZV[QU%
MAH4976EN@ ",P/]^HJ7RWRT\%BQ6W'EE,5G$-DA*IJ.8AVH.)D3VHXPL"$1I
M& =RPWCY8,)=#*O-C?>QK**;_@,M+%X.>>ASAMC(CD/IUZFVB#<T$A8HTX02
MSC"SC!XRACLJ#,&$5BY-(AT"?2*Q)>4Z)!N#*9C40E&"R!365+3D'4%_FL#D
MD R/4U$R@F^A<@R;C7.!O'K")T7U.&[-V#ZQ1JG)#-$4U Z_;1R3X).>[50=
M?'LU8Q;L004]OA#.M'N/Y#RA2,XQ;/'JRL,=]O.Z\4$#L3H_*G?EF@KOWMDK
MN^D!Y9-D-QMFW)UJQWJ*_@;FQW0^Y4@%1=7FH7&U1,X$[U97:7,WPF!O%_'1
MFS)57D/'IRGA:K#,8S*F:&# 6UPK&<]M7MWG7[4/]#CZ*!2.>^.^FK=>U]+K
MS%A#?X[E%:*-MQ5R(:+114M\M%2("8P%3]6&N5M#WK6YT=D2I2Q7;A0XS?,Z
MIDVZY&5@1H'?3T *:7#HRBYCU:8-Q,;1BQ+%$)'I0D.O)NU'U):5N/7& @=;
MEEA7T5J89J%WZQ%1EDD#S11P"B>91/6&934KJ]01%XH@6G;'>5FN@H7<4UDJ
M%DAGN -^S2T>;O]&]EKN=:A[Q#Q0ER5QR(%[Q%X-I1=X.3*Q&5KU7LJ6#[CO
M=@*>0&)]8W?2+)DNLBCFW+AS+S54ICA:.KYQ\2Y"]_@Q &,R5-N=IN]H6!F\
MA)?[K4M60)P(V);16!C18=,]YERPP)XOZ"C^G-P*.VN0S'V"9'96"22S\BO[
M01@4PY@AS&IY#K/Y(UWZECX SWQA@&LS"<PJN/_R&=?;!66#<.W,4B&3=<3H
M?$ Z53FIFDL+2PDDQ^]$G"YIF&#'8>]QEOC6X]I=IYY?-W:OEG)E!2)QYIU]
M,6JH7A=1H$TVPQ0 ZBDB(@7S!*D#R2R_W<\S(7H33DWM'OP3C(Y&R8Z*8(2T
MK#!V$3>NZ*@O@5573M@A8<CP][;H/_9VJ:>\@B7B/"-\3O2S^J"8:" -Y9V'
MWYL$2:OW;GU0H-+%PLS M&K'!9[NE0(X3 A;+)<8H _^AKY:-@$+LBJ+?.A5
MSYM+2M;P\E@J V[:EM486,SK2^@?V(MIQ=!:9R[>"N,^7RC'JT%$C;E/MS?#
M, [>UI)8L2U]/3(.;4Z)2#H(82@IYQ^0)3;+-%IB\0_)%L>"T:E-)W5I$B-P
MM,R7?['G\B?$*5PWBNE"1I:14P^FTX@Q;)0N)R9%QZPE*<>!<"V:ZL8J8QK\
M41I)#SB7(.)LN#((K- OX;WIQ.[R9<DSI0*%3[TCQDH-+02#%4X0[75JL:SI
M&LO#Y4C&."M2[>.'<.L6J90H:JM\: '?N3 T PJ[\%]Z!,U'#3KT$O##VAYN
M^U79*%^:-A]C#NE561D^$7[K=BSD@@=E3J(7SB,[QQDU;IG(;3"B,3)UL![#
M#,ZH9&"+?C/VI<T-64/CO(+7R4J+H?R'1,?GUB)QH,/ZF@LS<FW.7>9XS]Y&
MWQ@E-3=73?0[E@%4V8];*-* L-Q #3^:)[$Z]=>?+VS, FU'+GLL1^QKDET
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MTQX-75/P3]P,=X\'M/2$,Q,L2".J+^3/QZ 7,26<\&F5DO$HOL*%=;L$I>J
M8SUA[4!**7BK6L5,I*1&&?ZCK ,)Z/F>\QT+=_5[=MQUV2O<MXR*NXZ *^,>
M49S+C$"[WI#76<",UA;FEE64O<OKAHY6 N!J\3?UP\8&%)YK<0<2Y!J)<E26
MO/((CY/A93::(Y'N5AC^]J. 4?X&>8@OL'1&&8P#V86KK.ZA97RC.R93W-(Z
M4P23%Q3HBB^TT$UA(#9[1^-/0C5OB_)ZDHTNLJXV.L86P8'S0S]-WV:UY!"L
M@(37CUA87:;$13ZXYM,A?K+B B^8&T6:;\8-^J!6L'7??PG_Y;V;Q+;NY@:M
M7(I0!2-H%58(-"DNS-* .!G3[S4T@<@JPJR:2ZMDWM*;4O&ZT;(AO;?3D&SP
M#Q]2/ N$VG')J!)$B6+?<SX$.N="17^B(CPG*>^HZ)8.:(@ZZB_++?1-WJ%I
MZ[IY+44OL+BYX;02^T;XC457VO')&,\B^45@5_/8#RYH!GRTUT1Y/_3RN>5X
MTO,WK56R,<0QHB.<H-I\_HBI^4:VU/TJNT0^<D4>&ZD@+ \<@YM0"J-?5<L_
MDN CN2B.+BGE!Q\S:[SL<>2A4J8N<Y*XHY!HR'G,7&M'V5"0TE9@<%E+R8[B
M%,5=&]J7 UO.3O@555RXL@]>Y,3WPI&X&*+0%%9*]W7@ES689XKZM*3'%%MQ
M]62$6_1[A:AL8V?!5^ VKW:7P"_YEOR2UV#U)*]^ A=]#E/[=@%>(%8>1^3(
M/3,M7A&P!!E3D/ 3XA!7D]^H/="?P?C'3B9Z<^.5ZJUIO14FQ68+S;3VO=8?
MI:0L)Y+-C,3TTXGT.-#("T6/^%->S0M/1$F_4!V4(TG.,6(D,NF2;,$<T3M5
MX)8<*?X9@Z*J2&C&@#Y!&NU==F/8AF'5HQ +1>]N>(ODGW3:-'=,M[J<7X3N
M<#^=%61AG#2L+^KC;SKD'7YEN?:)&?8N@_^@-LC[R@+\L Z3W6>8[(=5"I,]
MN)6^ZEV"V^T[NMT&'I"RYVV;8\R-R WWJA-2DO#0LV^5+'FLL*B0];3?/L*W
MX)Q$C$HJ+AC7^% 2)*^"NMMVR7DO6LFON 0CC]7G(SC.X<7MS%E:!O_;MUP
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M0T.J/&L$4$F1@8RFA[FXB0J](L=79M*/Q(+L$1F3!^8H/D +=F>;!:U>9V+
M[;Z;94CF*:9K-$X4VJNXO#W=3Y7ET_-Y!58 >T#X220N03<(S!3.T3#)Y#=/
MGNZ0CT7\[EB0Q&"@L;8ED[9 .S14B/1@X%1-\FRN=I9+MJN4HJ2).]2AM/K%
M+Q-6M(4S=WT"R@G(M?>Q ::,YD,^QEP?M%%B^VS#0%+(+*T-E*C#Q1O'SBL@
MVR.3:*_Q]I)T5,IV>6>L%':1CJYR!;;-X0^3?J)3H)$ $9"$+U8-'U^"W1AY
ME4'W7"IJG%>5X<?A]J H[,C J10?3W%85H:5'QSBL.^IAD@R*:L(5>: &$&.
MO&O:;V[,4J83/54!3P9VT&!LW8((H1@P?M E6L>$O9QFCU"[G((%M4KW,%@(
M8?8\1Y.L:4AG@IJ/EG2D0H!C+E'+6.X/]_T686NOCS[>=)8TZ;O,3I+_>31G
M7!**[8Q"GC8!,M&]8*B<J!#?U+:VDZI?P1E]<U;R^>-U5O(>LY+/'Z]25G(-
MWO_K)@23P.P6#1RG_N3VV)CH+8=IMXN,3C>#22>(I]0].0QQH[P:@N;ES_+K
M J"]RQ!I 5D,;J.%X6"#XUENLBV-^7<]AVNISD8L!<[I(U<670OIH7DU81O!
M6/ TF'TYC\WKZ=KD]]9]PU2@S3508\,F-\TJA@7J$T9^#.,C]A4<Z:O=I9UM
M+@QE,D4UMM5^F*@LGJ^RHQ*.>>%4,4IGA.36E$'7"]VZIG&D@DZ*TGO.IE0=
MUJCP;'JHDZ<EO( 7<'#2!Q[%G78*W>7XQV0K[7E4-&Y!W/ 2VR3#TFHKE:W.
M)#GA:]4BNLK3!$4P)D9_S<F"/^(_C$8$T T2JRK-"=.8$C\ 7AJU/$2ZCXG]
MAL'DD@X.514V-R*R"FDH[;1UWA,[]UT3T57X*\-@[<J// S4KU&JA0<<H AZ
M2A0B+:6SF_4GI"39#-6PI[AQA!-L/:6X1C&Z8UP#1A#[R0@$'#T< C"8S[9/
MMA,.7$A<?UA>%+"[8/W#Z!44NP!7IT(E;K!PKV2XMT8]D8$<-H@W($*66>-@
MOQKF\.*#A2-ZUQU&R4S8(+0S^';3:2 WPG^+C^36MHUC NXV9^M#_0OOTLXV
M%S$.E!ZL_BEY0[7TOL:_53T?BY-2^?VH+\7W^"]/,<9'/)7M9R-ED2!N<XU0
MLK?*;."D:33JUB 4GL&L'RMQMR(,9*-XV9%4)7!W'F\_^7M"5"IP1 C2-9*Z
M P\Y%;T2FRJ+2HKX&VH+,<#ND+:0WWZGM6'=/9Q$5;?'6'S%M.?!9A?2%][Q
M&=:V2:&(<LGA=N;Y,#.'Y$*(UFGZ_G*U!/QF<$,"A4J;007V2&!'E0C,($ W
M_P@7"_Z40_^0N]_6BVP1CSN6[P?\$3VMB@@YUR.OX(?B(7;[0U7W%TD:#/T\
M+6(EB!@+C=8XG4^:CJT=D$48G6Q<P?(X7J;=G1"12SQGM#O"[.94Q\IMD(D6
M2B!2\ U;5WMJ2FUHY%.2/[]#<QVZJG"LX3P($[HRDU)3NNW@N8L!>4(@O]ZE
M8HT)P>&R@XG**W&)?&;<+4D%I/$(,P]B0$HHO:-5V5T(?4<JW5EWG .06E=Z
MC82A3/:D#6D7_=PKEQ<9XNXDC%RR_!&Q7(LK,Z#A%O!.3OM&CK?V*F^W/!O9
M.H=!0-;H-(*CJ!Q#Z@,'N5^"YSDC7>>D-=U6WX!^"2-FR(ZAV20YJ-9W]Q?>
MI9UM+O3Y-2.3U!3V7,IO:+?BRJDX"481WB+G6I "-]6H='I S#4#QPQN_R4%
M]G$>>+"Y,5A-AY2G<?1(-M4BD33#@YJ$]ZPF>?YD';>]S[CMDU6*VSZXE;[J
M7=K9_DZXP(>80"LKO@0'-7HA=108$KUC&2M8H#FG%)A9D8USYV"X8"E?L3EY
MW>:58,:Y$%C*;P^3B.AG4;B#_M@^FE7 C0T7M.BBZ).EZD=JHI!=VS(7+!D&
M."(4V*UZ;>)*;)^T3:EZF1H-X[S2+J.7&!!:A/QNZ-<(?8N5,J<QH2),R9_6
MK21AV['Q\B?(UI8IACQ4Z<%Y!#]NU(^SB^G7R3,T;U*'S%]M-_+*,34O%7?+
M\I#*!9/0E#*%![6]'F"1PL[V]Q($QX.A&CTZ(E_I!6WW(3-&>#NLS>+@#@^N
M"(+OBZ]U[K[O[*:0BD6$DAG8RF06(>VKJ=%YMOW$9HAB^:1;']X&4 >/?ZJ6
M'!V.A@ ^RAVXY"C4V+8[$0VM1G@X)IVS47D*\424UZ"ND;Z''5TZD@+R1QD4
MHM>EN EB&?H&#,:GD*,Z3:TZ6+0<ZOGVD\?2!>^+;6[ *GGP5NZJ=VEG^P?:
MR;]P_!WN@_WT6I):L$FI$EZY<8;R"8U9*;:FGUQ!HT=Y@W G$XIC<P!,7-AE
M3>H)RY9<$(8Q]X):HW#3D27,)'XS6;9+BHWHG5@D9,D""(F//V@*Q&.,6'7,
MDVE6"(R:3?@$0)J=23YDV61XH(&)>627K<S"+C :[HBKE\@%;0U?."QU9]PP
MK39&])8V_[UXB@3)Q+LY?AEO75]R!O^<RA<;%U!-I4M\,($I5+'QXH^EU)'Y
M6+X?0P)4>[41M$?@<07]:YI-S^D?CAG(L0'5AOQ6*.\X2CZ9U_!.9*U0)B.:
M1^SB.$-2V@GEBZ"%-9R-PIQ*-X)PI>ET!_,EU%TYF#17Y9"*>NKY^31W"#[_
M:MB(55Z/<CG3+/7$![2BG[PHN5X4?OE;6EQBIJAPET0Z^G,^:K'V8A!P+EAA
M5?FDT3 RG_@W6OZE0#):Q%KABI'>EQ3,'L[K6GZ7!]3%L0LS#+0S;/NF+=UC
M3&)DN"G,*30=LGN$MPJ9?2K'F#L8:B37[R:^JX:3-)\FS/R8NT3HC.XN"H^V
M=*'M/ 8A69JYOC&78^^D.WV*T5B16<7;%Q&4&DN"5L _!&;-=KO[\FUKCP?#
MM=UG/L<*:G2GH*),]?<DD$!?D/.P6(C;$.T%NBZ<F&TQT%#RGDO6E'D:R8=9
M!8%RUNA/N1RM0RENT3*QU"KZIQXE7 W<5%+@FG1U_'@T8IIY)6[!N(_4+H&E
M1^M0\>EA G@793GBD[2>X\F4D^49'UBM#="3_:!L4Q#*]HAD-SCF9_B= ]4
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M-K97G#@R#*&@6*GC//$UW%CF(@FD:?HNG\ZGLE 3TF)-YW"^5\11U)$LI,O
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MG"9E.OL!?@@_?:]^5R>?ZGM1EI[G/P=QDM=)^2S8]%G/@GE4GJ?YO;I8_!S
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M4D889N"^")S+8?-=.RQW8%JNZ,\HHGSN!0K]SAI<?2\,WKY]Q0+-37AK7>]
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MY+KY>J2;OIS2/2YM4&T"7&=,%"0E^%K;B-X;P84MQ95$999RU )QZT4.^NO
M4<ZD?T8I?.@&.6SBN(IP<F5:6=$QK'; >%I=<U>QX#W#YFVV(ZHS'DMTT%\7
MZ"IZ+EGKZY"@LHG=)(AX3P3VB*.&JPHHDR*>?.@&8L@M-!%(:]K=I::B1,/F
MBJA''L9:GA)85H6"#I5BML=^$2G8CD#!BZ92D3HOB3]B<F8FU>?65P2]%8+H
M\&5)!'?U@_T5][(;A^H-!U"<1 5(5,[.R1SWC*+CDUO$+"JN9Q&T:+28%:7U
MKTHT'DM0# 2$LVTF(-TZ >3+IY\0'UDC4CVG4)A%YNN[9Q%"I$[(,84R,)W(
M53K:CIJA700/@3G6<"/B5X:#+#GGNEN,]<G*ZR_@)6_C9^N+ LD0=*MGRIQZ
MF/P][&%[P4GOO(>#&YGXRI/8MCE/)9)O!W#L\VF"XG841F?-#6*82/S*(D>?
MDX!Q#%+%WQXEBZ)*ZP*F=(8-835"FU#1TGRUPE1R6EV@,1G#H:#.=1:8#0LC
M,(Q&D#VQRF9-SKNU%QQ605-I8&/HTB?TJ,0>5B3Y_G!0F1]PZ5$8))_PJ%0J
M$MK1RG1Z0]V/P$.0#2=['M%*."2>OB8,?$@5NCVJK/)EBZ>1Z).L.ZE//]RY
M\N"MMR?$H'@=I1E2_\.NRP7;/:!L1[RA=!Q?EP0,[P\YA^Q==6]-52QE7Q44
M.$3S@.H.O)U)Y$Z6#SSF0&@G#[UP(J;YA">T0!'=.*^;XN2+0P VB'DE7-*B
MUFYJ9Y(AHY>J.$47SOV*%?%EI]*O+E7$%C5CW90ZSZ(:7)+V$KW<"=%:8>+V
MC>SM%NNLFHX5.R]V;G*_$E?$:XKR2I[:9HN4=8$O?A=:8G6P]^DNV'N-P=ZG
MVQ3LW?X+Y([>BG(MGNC:KN!P0O!8D(3W48F-635X#K38$<,\38S89W690C'B
MX=)I_C56L8?V\K.(*27-1K5[,@=!2,!#56P5;J32 D/*I:X!BL@P(__ !*;V
MCN%"S>&0,+4-=9SC(K:KB&:$#K<PM?D**2@XR6UO!>?#=P,UC5ZJ0?S93,^Y
MY.X\2O.JYA(VL)XK\>;,0+WC463=25W,9LC2T*"FB;,HG5/$M6@6S,ML@$+X
M&W8KQ6F59Z!>B"^X8 :=-[#/Y4^3I7/?R??9K5!#Y>FX4M"^C>6'EVF1F3_P
MN^P_SJ@4VWTI&U#ZK0MZJ["A>O96:G+2,F[FZ&[$VKG$6AO+PZ9EX1=98_?
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M,M(8-LM6$Q88+2J*E;'+Q"$3]/LB#L59U9ZN.T;OF!%*5T\@]?(1\C?5=]S
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M=1L\DDQ;J5#)3*O <MK>$!WU]O)'T&^)/2+55!=5WW:OX:1&/Q]M1ZZU2^2
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MZG2Q4G_%_M8(FD&<LDU)&2K3QX3Y.OAUON>8*&7!]CLAL^D.IDH2!:;F&)J
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M=8+S>?<?/SQHW\_]M_WU%=*_>7&_NN\4]H;!KWM'(#MO7N@-@'O4C/>SY[_
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MLF ?-7B+38QWR-RO1N8>?"DR][O SMY_>7+T+SQ7]W\Y^_7MB_\/4$L#!!0
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M<VCS;7#T%GZ(?&EPNA\<X"#O#P:'N_O!IX_P[> 0Y_+AXRD^^O;XZ(-,XGA
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MAMKPY@@A'4GSR!JU4Q:^H;-E1%1Z;U2U=1R7N&<&(<$](9EM,^&VWY,''>Q
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M,] /#@14C=70E%O3="*W.ZH;;M$H9^,3'1'L*R)0A2GR,<^9$%G&(Q.NVT]
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MCCZKHFP%8HIOW<F* E7P,Q [5J6[5H9BSH=H$VE7RQ]&\I'I:;V8,2:TEH:
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M\05I9V,GHI3'!)]@#=JMRA);J%R>>I"GJ'^8&!B:&P\DH7EQ!O OZPS@:\P
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M ,U+N=41:"/ VOALE2*:;90GQ:S"?">L(K;WN:6UD&MX@&["N>C 1JDE$3Q
MW>+_]N@_[7XE@8.[ZM*KJ'7.QC3SF#"G,LE'5N*/2@/A>A.W%8H';"K;P3G]
MP%W.SA)C(\@O$]T6$!U"!N\)[]=7[(>'.V0Z!DILX=XY&[[#+;[]9.T7OT:_
M^/:3M6/\(3K&S]C-]UFKW):S:&>N.#<;O2=N,\'V=GE>=NN'J/R2U*X80%9G
M%Q<QWV6[EY(/_ @_2,.9]/5"53Z04B3?%Z3@@KE:!R>FNG@*.\?WTH#L+[?*
M"E5]RA#K42@Y(58%*9Z*?F/,]^XPWM5>DMT:Y+EN#7)JF<M"5NO6("NT+&D-
MHHX1A%@FR:P.7QIYW8")'QA;V4+ISJ++2AM((\Q19/[EM&=6WNSGF%_!6KVD
MQ10M.1GZZ:UMQ30T@NY I:J&S>0E4E+9RC1Y?%>@0BB/%+H1I!2*7[')UJG>
M)VD)>XGIUV*LH#LI5%85<M*6%ETJ51788XYH?NA+&NOF!I9CO^#>C-AE["SG
M[JQGO$RWY:U)VM6@.(TQ70>678<6U76$G9@#216*9QDE-XUF#-+"PL-M%TGS
M(-L$E+TR3SB1AW/(K0P8PBR<LS123**.OEJ-6+3W9L)ID\KCH1Z7O#R!8=8[
M&J%C(1UK@TX2&R4_OLTRD@71/)4%&@4Y7!)=$5JJ/U9J?S )23O :&^Q@@B7
M+7^I*/1L;D&H>HVRT2J=.<2K9O^]:K$]K;1A=#Q: $>F$02C?J/Y:N94^"N1
MM&1M<'64P*+U7!5J+;'R:33:=NC($O4^A_N?9=AAPRO!IEO#-=ABOONEV,W4
M+,&XM-M_3\_G%>KL:)OIXW8FY?8Y#&8YI669=V,26:57Y>6=YD"D61::E/\.
MI-KEQM8%$<" J##*JEVI="V1Z[*RAA(Z1%YI7UVZE=Y(_+7?S%6MARUS70&;
MCDTS0K4/5")I50>H=NJA*E0TE;64RX[T)& :EE=2P5;Y83W%1<^C"Z[4LLF1
MLQ76ZL"*+$NZB1R:$Y1\GE.;\E0WSI0=8>3KHMY2DFG/(0S-4(G/H],%4Q:)
M&XDC3S7\0;NVPN)>+0N=8OANF:<<[L1.Y[H7>#01 \KENOK>6P1J.YV95D&<
M,/-84OHMU).,HA-MAE8;=BT1G?:F%**YL*2"ZM=#<L>J#K\6(>=5OR2MSXD[
MGD_:FD9[3WC'C8HI8&8\SEI"@2]+KVS4L<KXOV.%X T#<.ZJSI 5]Q\>BZ?J
MZ5^C\"._CW)W6@\:I^!5F0H:J,;X1UE!6C.R%5F6=#WPXX**F?F7IU1Q0Q=.
M@C@7!VC454"?MU0S>XB,?(VB6D?P-BC>;TH&VR9C4--:U$X)#2GX>F::7$--
M39@*^K^['F0EZ(=AA0Z+OCGM0*TPT>]K6":L2$5#"@TG#!6N1VU&)QTL'WE,
MQ7(\I'##1D.V\\B!A(%TXNHJ43/$P2G/:%3/*.W"#@,H7?*!W,$KW/3;:S?]
M=;KIM]=N^H?HIH]=]Q>P9NYK;Q+9!9V9?.2I8<W=#IX6Y!Q'X_.>9U5.?2MV
M8\,,5PTA4N*76(-D\7,W>]0*ESIN+)-CJ5+Q$U1/E=]N,&)-BKYT $KHAUXC
MOB$6=E9?YNSN4R5*H'6>I:I.&57Z+-'6(28?3:0Y$*+I/2K&C^B!TMIR,B4D
M",%A<C1==9Q<.0N:+0N/9_"F[>?/FP$1^0G[:HQ#4M*[+$0> R3M=YFA;G'R
M;=("72J"TZH_"-D0L*H'VSV:+[;^VNW1?"!R;O67)44PQXECXSIX!T;O5*@$
M\C4#8FNO3$&=H.0];,.:[$X"T*(,(P/DZC;$)==H$VA1O9G@051;+=OB\\V>
M)E0N@^Y2V>1EKFO;<7X*P0YNUT4*>T8YC.PX,FH@>G>))219IF^<-[J**49E
MK5-]@)E>I$7FI(5Z3$M^MH!A]7O I4)E_MEL QE09;-2,DDQ12V).]GD.E)Y
MQY=D1RI?Z$CEA[1"[S7G1ZUCE"NTK$B53*G&IB!P3TSF>?")FD.II 50[K&%
M<5UGK.T "]F-JO,6-V9<))P3*RELMLP7/YU IDL>//:LX,Q6JQMQJ><4V?GP
M'27Y*K70-9NCCOCHTXUX$Y2]T')=Z?0U1/YM^<FSK>!7.ZPI +DZW18S@LT:
M%3BDSXIS@_J.F:0495&35J 5#DZ)F?%H,RB<=U,JJD3GVAM-RS))G+B?76Q*
M0(G\(WDA67^L%-O;.TP8&4R%DG+8&QJX(DIPP%\\!6[-!U9D61*<>%]4\!#H
M4F/0O??0>IB-5)CU R(&:FW!3DAQG&2C LC(*%7*S9>DL#Z_S\I8(SU9&#-8
M+^+B7IF6=1G-K^;YQ>[\)L[\7%#BTI34!"-TBU VM@(/,A K[ET5AQI:G1*>
ML\;GR+.>04B%*W \DUS@.33*U0)$K[06>%/MHU0C6;,)52DB\E-.L4@D %W5
M$MRG>PH&F("S>(D2^)%$F/4&.6HB3M??'(IWRJ9BZ*:V*ZQ(W956M MB(LT=
MQTU,OV#2',77\<><@5'I2=DSI7W)TF3F3YD4X<;KU_QF198E,823J)Z56"H$
M3R+R"O[A'=5&X)^2>J1+%^GV8Y$14LUTBC W24R@I<I]7NM,%[)9-%]@I6":
MEIKTM<S6&1)$350A*/DZ:>YZAR([!4'@_+EPEL=1J,14;J3 'GF,1AZ 9.;D
ML,$,J,AHHC) OP<C/! ZOL(/_W3MA[]./_S3M1_^ ?OA!P8UB[6;&X7%6&ZM
MVRLD*Y=<TK4?WZFM=KG*==A2_F5KL7YKR[1FO0U]A:5J6T")-X8V.$XA*24N
M("DFBNH4U ;>#N88<OE>*_Q:BTM4YZC:UB/9\\I?+X9U$V1OJ]^S;0YIAN#;
M'JDDQY@Y-((_IK"0$O[43M2BG5>2-E5B:[F"\IE@9N699&-Q$E,\X])('$KG
M224(S8?%*<LLVLD"[%ZT8V?12=:D@6<9'@W5FFJX7P5C6BG]P\Q( )155[<V
M?[%*FA(\I,I49HIRI$-/M@>9DJLM9W$67;)K6I7:A#;^@1UO:JW X;WJ:+HH
M,\S0NQQW6*!2)!R99"F=5^FDAO$JESX9'410>2HVM'"*6; .0J_.5_V6]W!;
ME;G*6VT]I*[$4TSTPEQS<ZM#+N%%VUHEXB&USU7;#XPTY(BX4%4:<!B[.@A
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MY%C8!(B;F[XMO'Q"!UA (3+J-*3;.5TN;8SX:L@7#()?K0A:X9R>7O"JA:I
M+FM".N<PQ<.&@:1M;'"=/A22/X+16(RS!+,#+/!C1(4=M%/[7=,B!=NN/V
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M<_72^K39^,'?74Z_#LXW_6[EP!SWVD[QC5R1S8YGS?!G/Q@X^_\/4$L#!!0
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MJ1!SE_">*@B+X&.8;BY!R5KH20HE.=3#*SB)W<J83Z'>T/C:40Z,I#U&*"S
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M,2YH=&U02P$"% ,4    " "H@/9:=!'4/ 9(  #LUP$ "0
M@ &H% $ 97@T+3$N:'1M4$L! A0#%     @ J(#V6E<=*'%@'P  :]\   L
M             ( !U5P! &9O<FTX+6LN:'1M4$L! A0#%     @ J(#V6@(W
M+R\M P  [@L  !$              ( !7GP! &YA;W8M,C R-3 W,3@N>'-D
M4$L! A0#%     @ J(#V6ET7W^?]"@  ?X8  !4              ( !NG\!
M &YA;W8M,C R-3 W,3A?;&%B+GAM;%!+ 0(4 Q0    ( *B ]EKI&=^F70<
M -Q7   5              "  >J* 0!N86]V+3(P,C4P-S$X7W!R92YX;6Q0
52P4&      < !P"D 0  >I(!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="naov-20250718.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326706</identifier>
        </entity>
        <period>
            <startDate>2025-07-18</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-18" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-07-18" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-18" id="Fact000005">0001326706</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-18" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-18" id="Fact000011">2025-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-18" id="Fact000012">NanoVibronix, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-18" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-18" id="Fact000014">001-36445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-18" id="Fact000015">01-0801232</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-18" id="Fact000016">969                                             Pruitt Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-18" id="Fact000017">Tyler</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-18" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-18" id="Fact000019">77569</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-18" id="Fact000020">(914)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-18" id="Fact000021">233-3004</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-18" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-18" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-18" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-18" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-18" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2025-07-18" id="Fact000027">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-18" id="Fact000028">NAOV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-18" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NanoVibronix,
Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">01-0801232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">969
                                            Pruitt Ave<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tyler<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">233-3004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAOV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanovibronix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>naov-20250718.xsd</File>
    <File>naov-20250718_lab.xml</File>
    <File>naov-20250718_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "NAOV",
   "nsuri": "http://nanovibronix.com/20250718",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "naov-20250718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "naov-20250718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naov-20250718_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://nanovibronix.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
